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ABSTRACT 
Polybrominated diphenyl ethers (PBDEs) are widely used flame retardant compounds. 
Brominated diphenyl ether (BDE)-47 is one of the most prevalent PBDE congeners found in 
human breast milk, serum and placenta. Exposure to BDE-47 has been linked to adverse 
pregnancy outcomes in humans including preterm birth, low birth weight, and stillbirth. 
Although underlying mechanisms of adverse birth outcomes are poorly understood, critical roles 
of impaired trophoblast invasion and placental dysfunction characterized with dysregulated 
inflammatory pathways have been implicated. The present study examined the hypothesis that 
BDE-47 stimulates oxidative stress-mediated activation of inflammatory pathways in a human 
first trimester extravillous trophoblast (EVT) cell line, HTR-8/SVneo, and that the antioxidant 
transcription factor nuclear factor (erythroid-derived 2)-like 2 (Nrf2) plays a protective role 
against BDE-47-induced inflammatory pathways. 
Our results provide evidence of altered mitochondrial membrane potential, enhanced 
production of reactive oxygen species (ROS), and enhanced production of the pro-inflammatory 
interleukin (IL)-6, IL-8, and prostaglandin E2 (PGE2) stimulated by BDE-47 in human placental 
cells. The inhibition of stimulated release of IL-6 and PGE2 by a variety of antioxidant 
treatments implicates the involvement of ROS in the regulation of BDE-47-stimulated 
inflammatory pathways in HTR-8/SVneo cells. In addition, treatment with BDE-47 activated 
Nrf2-mediated oxidative stress responses as indicated by increased Nrf2 transactivation, 
differential expression of redox-sensitive genes, and augmented glutathione (GSH) production. 
Pretreatment with the Nrf2 inducers tert-butyl hydroquinone (tBHQ) or sulforaphane suppressed 
BDE-47-stimulated IL-6 production and nuclear factor kappa B (NF-κB) transactivation in HTR-
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8/SVneo cells, with stimulated Nrf2 transactivation, intracellular GSH production, and mRNA 
expression of antioxidant genes compared with non-pretreated controls. The latter findings 
suggest that Nrf2 may play a protective role against BDE-47-stimulated inflammatory responses.  
In conclusion, BDE-47, a predominant flame retardant chemical found in human tissues, 
activates proinflammatory responses in human first trimester EVTs. The present study provides 
the first experimental data to support a mechanism by which PBDE exposure could contribute to 
increased risk for adverse birth outcomes. By demonstrating that a common toxicological effect, 
oxidative stress, activates inflammatory pathways associated with impaired trophoblast function 
and placental dysfunction, these data provide support for a plausible biological explanation for 
environmental contaminant exposure associations with adverse obstetrical outcomes. 
Furthermore, this research contributes new information for potential interventions to reduce 
adverse obstetrical outcomes originating from abnormal placental function, with attendant 
possible economic, societal and public health benefits.
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 INTRODUCTION  CHAPTER 1.
 
The hallmark of placentation - trophoblast invasion 
The placenta plays critical roles during pregnancy ranging from anchoring the conceptus 
and preventing its rejection by the maternal immune system to enabling the transport of nutrients 
and wastes between the mother and the embryo/fetus (Maltepe et al., 2010). Proper placental 
development is a prerequisite for a successful pregnancy. Placentation is a unique biologic 
process which involves the intimate dialogue between fetal and maternal tissues leading to 
profound remodeling of the uterine vasculature. Invasion of extravillous trophoblast into the 
spiral arteries is a key event during placentation (Brosens et al., 1967;  Pijnenborg et al., 1983;  
Pijnenborg et al., 1980). The extravillous trophoblasts (EVTs) are a highly proliferative and 
migratory cell population that invades  the decidual and myometrial segments of the spiral 
arteries, resulting in the reversible remodeling of the arterial wall architecture (Anton et al., 
2012;  Brosens, et al., 1967;  Pijnenborg, et al., 1983;  Pijnenborg, et al., 1980) (Figure 1.1). This 
transformation leads to reduced peripheral vascular resistance in the placental bed, thereby 
maximizing blood flow to the fetus (Brosens, et al., 1967;  Pijnenborg, et al., 1983;  Pijnenborg, 
et al., 1980). Abnormal placentation has contributes to the pathophysiology of adverse obstetrical 
complications such as preeclampsia (PE) (Brosens, 1977;  Gerretsen et al., 1981;  Robertson et 
al., 1967;  Sheppard and Bonnar, 1976) , intrauterine growth restriction (IUGR) (Gerretsen, et 
al., 1981;  Hustin et al., 1983;  Labarrere and Althabe, 1987;  Sheppard and Bonnar, 1981), 
spontaneous abortion (Hustin et al., 1990;  Khong et al., 1987), preterm premature rupture of 
membranes (Kim et al., 2002),  and preterm birth (Kim et al., 2003). Although the mechanisms 
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responsible for improper placentation are not fully understood, impaired trophoblast invasion has 
been implicated (Zhou et al., 1997a;  Zhou et al., 1997b). 
 
Regulation of trophoblast invasion 
Trophoblast invasion is tightly regulated by trophoblast-derived as well as maternal 
factors in time- and distance-dependent manners (Bischof et al., 2000;  Lala and Hamilton, 
1996). These regulators include a number of autocrine and paracrine factors, including growth 
factors, growth factor-binding proteins, and proteoglycans (Chakraborty et al., 2002;  Lala and 
Chakraborty, 2003). Recently, inflammatory mediators such cytokines and prostaglandins have 
been shown to play a role in the regulation of trophoblast function during first trimester of 
pregnancy (Biondi et al., 2006;  Horita et al., 2007a;  Jovanovic et al., 2010;  Jovanovic and 
Vicovac, 2009;  Nicola et al., 2005b).  
 
-Cytokines 
Cytokines are small (8-30 kDa) hydrophilic signaling peptides and glycoproteins used in 
autocrine, paracrine and endocrine signaling throughout the body (Miller, 2009). In the placenta 
and extraplacental membranes, cytokines are produced by trophoblasts and diverse decidual cell 
types, and are assumed to play a role in establishment of successful pregnancy (Salamonsen et 
al., 2007) 
 Interleukin (IL)-6 is a pleiotropic cytokine that belongs to the family of gp130 cytokines 
(Dimitriadis et al., 2005).  IL-6 is produced by many cell types and is involved in various 
processes such as immune response, acute phase reaction and hematopoiesis (Jovanovic and 
Vicovac, 2009). It has been shown that IL-6 is released from human first trimester placenta in 
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tissue culture (Kameda et al., 1990). IL-6 was expressed in both syncytiotrophoblasts and 
extravillous trophoblasts (Jauniaux et al., 1996;  Kauma et al., 1993).  Receptor protein for IL-6 
(IL-6R) and gp130 have been detected in trophoblast (Nishino et al., 1990;  Sawai et al., 1995) 
IL8 (CXCL8) is a pro-inflammatory molecule belonging to the CXC chemokine 
subfamily (Jovanovic, et al., 2010).  IL8 is shown to play roles in regulation of neutrophil 
transendothelial migration (Huber et al., 1991), angiogenesis (Koch et al., 1992), and 
proliferation myeloid progenitor cells (Sanchez et al., 1998). IL-8 is constitutively expressed in 
trophoblasts and placental macrophages, and its expression is highest at term (Shimoya et al., 
1992). mRNA and protein expression of IL-8 was reported in cytotrophoblast, 
syncytiotrophoblast, and Hofbauer cells of the placenta (Saito et al., 1994). Expression of IL-8 
receptors, CXCR1 and CXCR2, has been reported in human first trimester EVT (Hanna et al., 
2006), cytotrophoblast, and the human choriocarcinoma BeWo cell line (Hirota et al., 2009;  
Tsui et al., 2004). 
 
-Prostaglandins 
Prostaglandins are small lipid molecules synthesized from membrane phospholipids in 
response to various physiological and pathological stimuli (Nicola, et al., 2005b). Prostaglandin 
E2 (PGE2) is one of the most extensively studied prostaglandins, with critical roles for 
successful pregnancy, including implantation (Psychoyos et al., 1995;  Yee et al., 1993), 
immunoprotection of the semiallogenic conceptus (Parhar et al., 1988), and parturition (Keelan 
et al., 2003). Prostaglandin production begins with arachidonic acid liberation from membrane-
bound phospholipids by the action of phospholipase A2 (PLA2) (Jakobsson et al., 1999;  Kuroda 
and Yamashita, 2003;  Stichtenoth et al., 2001). Then, liberated arachidonic acid is converted to 
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prostaglandin H2 (PGH2) by two cyclooxygenase (COX) isoforms, COX-1 and COX-2 
(Jakobsson, et al., 1999;  Kuroda and Yamashita, 2003;  Stichtenoth, et al., 2001). Finally, 
prostaglandins are further isomerized by tissue-specific prostaglandin synthases. In the case of 
PGE2, PGH2 is converted to PGE2 by PGE2 synthase (PGES) (Horita, et al., 2007a). 
Prostaglandins can be further catabolized to biologically inactive keto-metabolites by 15-
hydroxyprostaglandin dehydrogenase (HPGD) (Tai et al., 2006). It has been reported that COX-
2 and microsomal PGES-1 are expressed in human first trimester EVT cells (Meadows et al., 
2004). 
 
Inflammation and adverse birth outcomes 
There is a growing body of evidence that improper regulation of the inflammatory 
networks may lead to adverse pregnancy outcomes (Orsi and Tribe, 2008;  Tjoa et al., 2004). 
Specifically, increased levels of cytokines, prostaglandins, adhesion molecules, and C-reactive 
protein in cervical fluid, amniotic fluid and maternal serum have been linked to the 
pathophysiology of preterm birth, PE, and IUGR (Cox et al., 1993;  Goldenberg et al., 2005;  
Lyall et al., 1994;  Romero et al., 2002;  Tjoa et al., 2003;  Vince et al., 1995). High levels of IL-
6, IL-8 and PGE2 in the cervicovaginal fluid and amniotic fluid of pregnant women have been 
associated with increased risk for preterm birth (Dortbudak et al., 2005;  Goepfert et al., 2001;  
Romero, et al., 2002;  Wenstrom et al., 1996). PTGS2 mRNA levels were approximately seven 
times higher in chorionlaeve from spontaneous preterm extra-embryonic membranes compared 
to non-laboring tissues of equivalent gestational age (Mijovic et al., 1998). Through pathologic 
activation of pro-inflammatory pathways, pregnancies complicated with bacterial vaginosis 
(Flynn et al., 1999;  Leitich et al., 2003) or intrauterine infection (Goldenberg et al., 2008;  
Romero et al., 2001) have been associated with increased risk of preterm birth. These studies 
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suggest that inflammation occurring at the maternal–fetal interface during pregnancy contributes 
to adverse obstetrical outcomes. Although the etiology of inflammation-related adverse birth 
outcomes is not fully understood, it has been recently suggested that inflammation within the 
gestational compartment may lead to impaired trophoblast cellular function, contributing to the 
placental dysfunction seen in pregnancy-related disorders (Anton, et al., 2012).   
 
Inflammation and placentation 
A possible link between placental dysfunction and inflammation has been implicated in 
studies showing that women who delivered preterm had higher rates of placental ischemia and 
abnormal placentation than controls (Germain et al., 1999;  Kim, et al., 2003), with high levels 
of IL-6 and IL-8 in cervical fluid, amniotic fluid and maternal serum (Goldenberg, et al., 2005). 
In HTR-8/SVneo cells, LPS reduced invasion activity (in a matrigel-based assay) with increased 
production of IL-8 and IL-6 (Anton, et al., 2012). However, treatment with IL-6 increased 
gelatinase (matrix metalloproteinase-9) activity when assessed with a gelatin zymography assay 
(Jovanovic, et al., 2010;  Jovanovic and Vicovac, 2009). Inhibition of endogenous IL-6 in JEG-3 
choriocarcinoma cells inhibited migration and invasion (Dubinsky et al., 2010). Roles for PGE2 
in trophoblast cellular function have been suggested, also, although reported findings are not 
consistent. For example, PGE2 promoted migration of HTR-8 cells with suppressed migration by 
COX-2 inhibition (Horita et al., 2007b;  Nicola et al., 2005a), whereas Biondi et al. showed that 
PGE2 suppressed the proliferation and migration of HTR-8/SVneo cells (Biondi, et al., 2006). 
Despite the inconsistencies, these published reports suggest that inflammatory mediators 
including IL-6, IL-8 and PGE2 may play critical roles in regulating trophoblast cellular function 
during placentation.  
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Reactive oxygen species as a signaling molecule 
Oxidative stress is defined as the imbalance between cellular pro-oxidants and 
antioxidants resulting in increase of reactive oxygen species (ROS). Oxidative stress in placenta 
has been associated with pathologies of pregnancy, including preterm labor, PE, and IUGR 
(Agarwal et al., 2012). A growing body of literature has reported that ROS can function as 
signaling molecules in mammalian cells (Finkel, 1998;  Khan and Wilson, 1995;  Remacle et al., 
1995) to regulate signal transduction pathways that control gene expression and posttranslational 
changes of proteins (Allen and Tresini, 2000;  Palmer and Paulson, 1997) involved in various 
cellular functions (Droge, 2002;  Valko et al., 2007). ROS can activate a variety of transcription 
factors, including nuclear factor kappa B (NF-κB), activator protein 1(AP-1), and nuclear factor 
like 2 (Nrf2), leading to altered expression of genes for inflammatory cytokines, chemokines, 
and anti-inflammatory molecules (Reuter et al., 2010). Moreover, N-acetylcysteine, which can 
act as an antioxidant by increasing cellular concentrations of glutathione, prevents 
lipopolysaccharides (LPS)-stimulated parturition, fetal death in mice, and LPS-induced release of 
pro-inflammatory cytokines from human extraplacental membranes in vitro (Buhimschi et al., 
2003;  Cindrova-Davies et al., 2007). Together, these findings implicate interplay between 
oxidative stress and inflammation in the etiology of adverse pregnancy outcomes. 
  
Nrf2-Keap1 pathway: cellular defensive mechanism  
To defend against exogenous toxicants and injury, cells possess a variety of 
cytoprotective and detoxifying enzymes. The expression of some of these genes is regulated by a 
common promoter element called the antioxidant response element (ARE). Nrf2 is a redox-
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sensitive transcription factor that binds to ARE and activates the ARE-mediated gene expression 
(Itoh et al., 1997;  Motohashi and Yamamoto, 2004;  Osburn et al., 2006). Under basal 
conditions, Nrf2 is sequestered in the cytoplasm by the cytosolic regulatory protein Kelch-like 
erythroid cell-derived protein with CNC homology (ECH)-associated protein1 (Keap1) (Imhoff 
and Hansen, 2010). While sequestered, Nrf2 constantly undergoes ubiquitination and subsequent 
proteosomal degradation. Keap1 contains many cysteine residues which sense changes in the 
redox status in the intracellular environment and are modified directly through either conjugation 
or oxidation to a sulfenic acid (−SOH) (Imhoff and Hansen, 2010). Modifications on the cysteine 
residues causes a conformational change of Keap1, leading to the release of Nrf2. Then, Nrf2 
translocates to the nucleus and binds to ARE (Rushmore et al., 1991) resulting in the 
upregulation of phase II detoxification enzymes and antioxidants such as NAD(P)H 
dehydrogenase, quinone 1 (NQO1), heme oxygenase-1 (HMOX1), glutamate–cysteine ligase 
catalytic subunit (GCLC), and glutamate–cysteine ligase modifier subunit (GCLM) (Kensler et 
al., 2007).  There have been extensive studies on the protective role of Nrf2 against carcinogens 
and xenobiotics in vitro and in vivo (Fahey et al., 2002;  Kensler, et al., 2007).   
 
-Anti-inflammatory effects of Nrf2  
Recently, many studies provided evidence implicating the anti-inflammatory effect of 
Nrf2 in a variety of experimental models (Khor et al., 2006;  Rangasamy et al., 2004;  
Rangasamy et al., 2005;  Thimmulappa et al., 2006). In response to traumatic brain injury (TBI), 
mice lacking Nrf2 exhibited increased intestinal inflammatory response and mucosal injury (Jin 
et al., 2008;  Jin et al., 2009). In addition, oral administration of the synthetic Nrf2 inducer tert-
butylhydroquinone (tBHQ) decreased NF-κB activation, inflammatory cytokines production 
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(TNF-α, IL-1β, and IL-6), and ICAM-1 expression in TBI-induced gut injury in mice (Jin et al., 
2010). In rat neuron-like PC12 cells, tBHQ inhibited LPS-induced cyclooxygenase 2 (COX-2), 
TNF-α, and NF-κB expression in a dose-dependent manner while stabilizing Nrf2 (Khodagholi 
and Tusi, 2011). Moreover, pretreatment of murine BV-2 microglial cells with tBHQ attenuated 
the LPS-derived overproduction of pro-inflammatory TNF-α, IL-1β, IL-6, and PGE2 (Koh et al., 
2009). Although the precise mechanism regarding the anti-inflammatory ability of tBHQ remains 
elusive, several lines of evidence indicate that the anti-inflammatory properties of tBHQ might 
result from the augmentation of the cellular antioxidant response via up-regulation of the Nrf2 
signaling pathway and inhibition of NF-κB signaling pathway, along with suppression of MAP 
kinase (p38, ERK1/2, and JNK) phosphorylation (Jin et al., 2011;  Khodagholi and Tusi, 2011). 
 
-Nrf2 in gestational compartments 
Despite the importance of Nrf2 in cellular anti-oxidative and anti-inflammatory 
responses, there have been relatively few studies regarding Nrf2 activation in placenta and 
pregnancy. In vitro cell culture studies have been a useful tool to show the involvement of Nrf2 
in the regulation of placental cell functions. It has been reported that Nrf2 may play a critical role 
in regulating angiogenesis by human umbilical vein endothelial cells (HUVECs) (Valcarcel-Ares 
et al., 2012) and human choriocarcinoma BeWo cells (Kweider et al., 2011). In addition, genetic 
profiling of highly migratory human EVT and villous cytotrophoblasts revealed that reduced 
expression of HO-1, a hallmark of Nrf2 activation, is associated with decreased cell motility and 
trophoblast invasion (Bilban et al., 2009). Wruck et al. provided the first experimental data 
showing that Nrf2 is active within cytotrophoblasts of preeclamptic placentae, with PE 
associated with increased Nrf2 activity compared to normal gestation-matched controls (Wruck 
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et al., 2009). Later, Kweider et al. (Kweider et al., 2012) reported that not only cytotrophoblasts 
but also extravillous trophoblasts are a source of Nrf2-regulated proteins in human placenta. 
Moreover, the latter study showed that extravillous trophoblasts showed an increased 
cytoplasmic expression of Nrf2 and 4-hydroxynonenal (4-HNE), a marker of oxidative stress, in 
IUGR/PE cases. In addition, the genome-wide transcriptional profiling of preeclamptic and 
normal pregnancies showed that the Nrf2-mediated oxidative stress response is upregulated in 
PE (Loset et al., 2011). Another study appears to contradict the prior studies, reporting that Nrf2 
activation and HO-1 mRNA were significantly decreased in preeclamptic placentae compared 
with normal controls (Chigusa et al., 2012). Nonetheless, when assessed together these reports 
suggest that Nrf2 may play a critical role in the regulation of trophoblast cellular function and 
invasion, and that dysregulation of Nrf2 may contribute to the etiology and progression of birth 
complications. Although studies have linked Nrf2 to adverse pregnancy outcomes, the present 
study is the first to explore the role of Nrf2 activation in the regulation of inflammatory 
responses in the gestational compartment, to the best of our knowledge. 
 
Environmental exposures and adverse birth outcomes 
There has been increasing global concern over the adverse health impacts attributed to 
environmental pollutants (Luo et al., 2010). In particular, maternal exposure to various 
chemicals, such as heavy metals, xenoestrogen and tobacco, during critical periods of pregnancy 
has been identified as a rising public health concern, because those chemicals are reported to 
pass across the placental barrier into the fetal blood stream and can be transferred to the fetus 
(Barr et al., 2007). In addition, there has been growing evidence that environmental exposure can 
play an important role in the etiology of adverse birth outcomes (Stillerman et al., 2008). For 
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example, cigarette smoking has been associated with increased risk for PE, preterm birth, low 
birth weight, IUGR, and pregnancy loss (Cnattingius, 2004;  Delpisheh et al., 2006), associated 
with increased systemic markers of oxidative stress and inflammation (Yanbaeva et al., 2007). 
Similarly, air pollution (Sram et al., 2005) and organochlorine pesticides including 
dichlorodiphenyltrichloroethane (DDT) (Pathak et al., 2010)  have been associated with adverse 
birth outcomes with increased markers for ROS. Exposure to lead and phthalates has also been 
associated with increased risk for IUGR, low birth weight, and preterm birth (Dietrich, 1991;  
Jelliffe-Pawlowski et al., 2006;  Meeker et al., 2009;  Torres-Sanchez et al., 1999). A critical 
knowledge gap that is identified and addressed in this study is the lack of information on 
biological explanations that link environmental contaminant exposures with adverse birth 
outcomes. Because pregnant women are constantly exposed to many environmental chemicals, 
an improved understanding of the impacts of those chemicals on gestational tissues is warranted. 
 
Polybrominated diphenyl ethers – growing public health concerns 
Polybrominated diphenyl ethers (PBDEs) are commercially produced synthetic flame-
retardants consisting of two phenyl rings linked by an ether bond with variable hydrogen to 
bromine substitutions (Figure 1.2A). PBDEs have been used in textiles, plastics, building 
materials and insulation (Miller et al., 2009b). Because PBDEs are not chemically bound to the 
products, they may migrate from the products into the environment. In addition, they are 
persistent and bioaccumulative because of their lipophilic chemical properties (Frederiksen et al., 
2009a). Due to widespread use and bioaccumulation of PBDEs, human exposure to PBDEs 
increased exponentially over recent decades (Hites, 2004). Analysis of 2,062 human serum 
samples from the NHANES 2003-2004 detected PBDEs in nearly all participants, with BDE-47 
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(Figure 1.2B), one of the most prevalent PBDE congeners, having the highest concentration of 
the PBDE congeners measured (Sjodin et al., 2008). Moreover, PBDEs have been reported to 
exhibit neurodevelopmental (Branchi et al., 2003;  Viberg et al., 2006), hepatic (Zhou et al., 
2001;  Zhou et al., 2002), immunological (Fowles et al., 1994;  Thuvander and Darnerud, 1999) 
and thyroid toxicities (Zhou, et al., 2002) in animal studies, leading to growing public concerns 
about their use.  
Because of PBDEs’ environmental persistence and toxicity, the US EPA has identified 
PBDEs as a priority human health concern (U.S. Environmental Protection Agency, 2006). 
Production of penta-BDE (tri- to hexa-BDE mixtures) and octa-BDE (hexa- to nona-BDE 
mixtures) ceased in the United States and in Europe (European Chemicals Bureau, 2003).  
Recently, tetra-, penta-, hexa- and hepta-BDEs were listed as persistent organic compounds  at 
the 4th meeting of the Convention of Parties of the Stockholm Convention on Persistent Organic 
Chemicals and banned in over 160 countries (Stockholm Convention News Release, 2009). 
Deca-BDE is still produced, although Sweden and some states in the USA (Maine and 
Washington) have prohibited the use of deca-BDE (Costa et al., 2008;  Frederiksen, et al., 
2009a).  
Despite these efforts to limit production and use of PBDEs in recent years, PBDE 
exposure still persists and remains a potential risk to human health. The globalization of 
commerce has allowed access the goods from regions with little or no regulation on PBDEs 
(Miller, 2009). Furthermore, there still exists a wide stock of old products containing penta- and 
octa-BDEs, allowing continued exposures. Moreover, a growing body of literature suggested that 
highly brominated deca BDEs could be degraded into lower brominated congeners (Stapleton et 
al., 2006;  Thuresson et al., 2005). Finally, many PBDE congeners have long environmental and 
12 
 
biological half-lives (Hakk and Letcher, 2003), which lead to persistent exposure to PBDEs after 
disposal of the products. Besides, the potential risk of bioaccumulation through the food chain 
has been implicated in many animal studies (Debruyn et al., 2009;  Letcher et al., 2009;  Yu et 
al., 2009). High levels of PBDEs in human samples from people who work at recycling facilities 
have also been reported (Bi et al., 2007). 
 
 -PBDEs and reproductive toxicity 
Limited studies report possible reproductive toxicity of PBDEs during pregnancy. 
Rabbits orally exposed to PBDEs show decreased gestation length (Breslin et al., 1989). In 
human studies, Main et al. report a significantly higher risk of cryptorchidism for sons born to 
mothers with elevated PBDE levels in breast milk (Main et al., 2007). In addition, Chao et al. 
found elevated levels of PBDEs in breast milk correlated with decreased infant birth weight, 
infant birth length, infant chest circumference and infant body mass index (Chao et al., 2007). 
Elevated levels of PBDEs in human umbilical cord blood have been correlated with preterm birth, 
low birth weight or stillbirth (Wu, et al. 2010). Although these studies suggest the association 
between PBDE exposure and adverse birth outcomes, and PBDEs distribute to human placenta 
(Frederiksen et al., 2009b), extraplacental membranes (Miller et al., 2009a), amniotic fluid 
(Miller et al., 2012), and umbilical cord blood (Frederiksen, et al., 2009b), studies of 
mechanisms by which PBDEs act on gestational tissues during pregnancy are limited. 
 
-PBDEs and Oxidative Stress 
A few studies suggest that PBDEs induce increased generation of ROS in mammalian 
cells. He et al. (2008) showed that PBDEs induce lipid peroxidation and DNA damage in 
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primary cultured rat hippocampal neurons. Reistad and Mariussen reported that pentabrominated 
diphenyl ether (DE-71) and BDE-47 enhanced the production of ROS, potentially through 
NADPH oxidase activation in human granulocytes (Reistad and Mariussen, 2005). It is also 
reported that BDE-47 induced apoptosis in Jurkat cells, possibly through ROS overproduction 
and mitochondrial dysfunction (Yan et al., 2011). Shao et al (2008) reported that BDE-47 
induced ROS overproduction, loss of mitochondrial membrane potential and apoptosis in human 
fetal liver hematopoietic stem cells. Together, these reports suggest a close relationship between 
ROS formation and toxicity induced by PBDEs. However, there is no previous report on PBDE-
stimulated ROS formation in human placental cells and tissues. 
 
-PBDEs and inflammation 
Oxidative stress has been implicated in inflammatory disease, and a growing body of 
literature shows that ROS can play a role in regulation of inflammatory pathways (Finkel, 1998;  
Reuter, et al., 2010). Although BDE-47-stimulated oxidative stress has been extensively studied, 
little is known about interactions of BDE-47 with the innate immune response. It was recently 
reported that BDE-47-pretreatment of peripheral blood mononuclear cells from children with 
autism spectrum disorders exhibit divergent LPS-stimulated cytokine responses compared with 
age-matched controls (Ashwood et al., 2009).  Peltier  et al. (2012) reported that pre-exposure of 
human second trimester placental explants to a PBDE mixture of congers 47, 99 and 100 
enhanced placental proinflammatory response to heat-killed E. Coli, with increased IL-1β and 
reduced IL-10 production. In the latter study by Peltier et al.(2012), however, PBDE treatment 
alone did not stimulate proinflammatory cytokine production in placental explant cultures. To 
14 
 
our knowledge, there are no previous reports of PBDEs directly altering inflammatory pathways 
in human placental cells. 
 
Research hypothesis 
Although inappropriate activation of the innate immune response can lead to placental 
dysfunction and certain environmental contaminants can activate innate immune responses 
(Campbell, 2004;  Lin et al., 2010), there is a paucity of reports on PBDE-stimulated 
inflammation in first trimester placenta. Moreover, increased oxidative stress in placenta has 
been observed in pathological pregnancies, and ROS have been implicated in the activation of 
inflammatory responses in gestational compartments (Buhimschi, et al., 2003;  Cindrova-Davies, 
et al., 2007). The present study examines the hypothesis that BDE-47 stimulates pro-
inflammatory cytokine and prostaglandin production via a ROS-mediated mechanism in the first 
trimester EVT human placental cell line HTR-8/SVneo. Furthermore, the roles of the redox 
sensitive transcription factor Nrf2 on the regulation of BDE-47-stimulated inflammation were 
investigated as a potential therapeutic target for adverse birth outcomes.  
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Figure 1.1. Trophoblast invasion during placentation.  
In the first trimester of human pregnancy, fetal extravillous trophoblasts (EVTs) invade the 
decidua and maternal spiral arteries. This physiologic transformation leads to reduced peripheral 
vascular resistance enabling the transport of nutrients and wastes between the mother and the 
fetus. Figure adapted from Wang et al. (2009). 
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Figure 1.2. Chemical structure of PBDEs 
A) General chemical structure of PBDEs (m+m=1-10). B) Chemical structure of BDE-47.  
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 INVOLVEMENT OF REACTIVE OXYGEN SPECIES IN CHAPTER 2.
BROMINATED DIPHENYL ETHER-47-INDUCED 
INFLAMMATORY CYTOKINE RELEASE FROM HUMAN 
EXTRAVILLOUS TROPHOBLASTS IN VITRO 
 
Abstract 
Polybrominated diphenyl ethers (PBDEs) are widely used flame retardant compounds. 
Brominated diphenyl ether (BDE)-47 is one of the most prevalent PBDE congeners found in 
human breast milk, serum and placenta. Despite the presence of PBDEs in human placenta, 
effects of PBDEs on placental cell function are poorly understood. The present study 
investigated BDE-47-induced reactive oxygen species (ROS) formation and its role in BDE-47-
stimulated proinflammatory cytokine release in a first trimester human extravillous trophoblast 
cell line, HTR-8/SVneo. Exposure of HTR-8/SVneo cells for 4 h to 20 µM BDE-47 increased 
ROS generation 1.7 fold as measured by the dichlorofluorescein (DCF) assay. Likewise, 
superoxide anion production increased approximately 5 fold at 10 and 15 µM and 9 fold at 20 
µM BDE-47 with a 1-h exposure, as measured by cytochrome c reduction. BDE-47 (10, 15 and 
20 µM) decreased the mitochondrial membrane potential by 47-64.5% at 4, 8 and 24 h as 
assessed with the fluorescent probe Rh123. Treatment with 15 and 20 µM BDE-47 stimulated 
cellular release and mRNA expression of IL-6 and IL-8 after 12 and 24 h exposures: the greatest 
increases were a 35-fold increased mRNA expression at 12 h and a 12-fold increased protein 
concentration at 24 h for IL-6. Antioxidant treatments (deferoxamine mesylate, (±)α-tocopherol, 
or tempol) suppressed BDE-47-stimulated IL-6 release by 54.1%, 56.3% and 37.7%, respectively, 
implicating a role for ROS in regulation of inflammatory pathways in HTR-8/SVneo cells. 
Solvent (DMSO) controls exhibited statistically significantly decreased responses compared with 
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non-treated controls for IL-6 release and IL-8 mRNA expression, but these responses were not 
consistent across experiments and times. Nonetheless, it is possible that DMSO (used to dissolve 
BDE-47) may have attenuated the stimulatory actions of BDE-47 on cytokine responses. 
Because abnormal activation of proinflammatory responses can disrupt trophoblast functions 
necessary for placental development and successful pregnancy, further investigation is warranted 
of the impact of ROS and BDE-47 on trophoblast cytokine responses. 
Introduction 
Polybrominated diphenyl ethers (PBDEs) are synthetic flame-retardants widely used in 
polyurethane foam, textiles, plastics, building materials and insulation (Hites, 2004). Among the 
209 PBDE congeners, BDE-47 (2,2′,4,4′-tetra-BDE) is one of the most prevalent congers found 
in human tissues and environmental samples (Hites, 2004). Because of PBDEs’ environmental 
persistence and toxicity, the US EPA has identified PBDEs as a priority human health concern 
(U.S. Environmental Protection Agency, 2006).  Limited studies reported possible reproductive 
toxicity of PBDEs during pregnancy. Rabbits orally exposed to PBDEs show decreased gestation 
length (Breslin et al., 1989). Elevated levels of PBDEs in human umbilical cord blood have been 
correlated with preterm birth, low birth weight or stillbirth (Wu et al., 2010). Although these 
studies suggest the association between PBDE exposure and adverse birth outcomes, and PBDEs 
distribute to human placenta (Frederiksen et al., 2009), extraplacental membranes (Miller et al., 
2009), amniotic fluid (Miller et al., 2012), and umbilical cord blood (Frederiksen, et al., 2009), 
studies of mechanisms by which PBDEs act on gestational tissues during pregnancy are limited.
 It is suggested that cytokine dysregulation alters extravillous trophoblast (EVT) 
processes, leading to placental dysfunction that may compromise pregnancy (Anton et al., 2012). 
For example, increased levels of inflammatory mediators such as cytokines and C-reactive 
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protein are associated with the pathophysiology of preeclampsia and intrauterine growth 
restriction (IUGR), possibly contributing to abnormal placental function (Tjoa et al., 2003;  
Vince et al., 1995). Also, women who delivered preterm had higher rates of placental ischemia 
and abnormal placentation than controls (Germain et al., 1999;  Kim et al., 2003), with high 
levels of interleukin (IL)-8 and IL-6 in cervical fluid, amniotic fluid and maternal serum 
(Goldenberg et al., 2005). Although these studies suggest that inflammation occurring at the 
maternal–fetal interface during pregnancy could contribute to abnormal placental function 
associated with adverse obstetrical outcomes, a recent report on PBDE-stimulated cytokine 
release in placenta, using second trimester human placental explant cultures (Peltier et al., 2012), 
showed that pre-exposure of placental explants to a PBDE mixture of congers 47, 99 and 100 
enhanced placental proinflammatory response to heat-killed E. Coli. However, to our knowledge, 
there are no previous reports of BDE-47 directly altering inflammatory pathways in human 
placental cells. 
 Oxidative stress is defined as the imbalance between pro-oxidants and antioxidants 
resulting in increase of reactive oxygen species (ROS). Oxidative stress in placenta has been 
associated with pathologies of pregnancy, including preterm labor, preeclampsia, and IUGR 
(Agarwal et al., 2012). A growing body of literature indicates that oxidative stress can activate a 
variety of transcription factors, including nuclear factor kappa B (NF-κB), activator protein 
1(AP-1), and nuclear factor like 2 (Nrf2), leading to altered expression of genes for inflammatory 
cytokines, chemokines, and anti-inflammatory molecules (Reuter et al., 2010). Moreover, N-
acetylcysteine, which can act as an antioxidant by increasing cellular concentrations of 
glutathione, prevents lipopolysaccharides (LPS)-stimulated parturition, fetal death in mice, and 
LPS-induced release of pro-inflammatory cytokines from human extraplacental membranes in 
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vitro (Buhimschi et al., 2003;  Cindrova-Davies et al., 2007). Together, these findings implicate 
interplay between cytokines and oxidative stress in the etiology of adverse pregnancy outcomes. 
 A few studies suggest that PBDEs induce generation of ROS in mammalian cells. He et 
al. (2008) showed that PBDEs induce lipid peroxidation and DNA damage in primary cultured 
rat hippocampal neurons. Reistad and Mariussen reported that pentabrominated diphenyl ether 
(DE-71) and BDE-47 enhanced the production of ROS, potentially through NADPH oxidase 
activation in human granulocytes (Reistad and Mariussen, 2005b). It is also reported that BDE-
47 induced apoptosis in Jurkat cells, possibly through ROS overproduction and mitochondrial 
dysfunction (Yan et al., 2011). Shao et al (2008) reported that BDE-47 induced ROS 
overproduction, loss of mitochondrial membrane potential and apoptosis in human fetal liver 
hematopoietic stem cells. These data suggest a close relationship between ROS formation and 
toxicity induced by PBDEs. However, there is no previous report on PBDE-stimulated ROS 
formation in human placental cells and tissues. 
 Although inappropriate activation of the innate immune response can lead to placental 
dysfunction and certain environmental contaminants can activate innate immune responses 
(Campbell, 2004;  Lin et al., 2010), there is a paucity of reports on PBDE-stimulated 
inflammation in first trimester placenta. Moreover, increased oxidative stress in placenta has 
been observed in pathological pregnancies, and ROS have been implicated in the activation of 
inflammatory responses in gestational compartments (Buhimschi, et al., 2003;  Cindrova-Davies, 
et al., 2007). The present study examines the hypothesis that BDE-47 stimulates pro-
inflammatory cytokine production via a ROS-mediated mechanism in the first trimester EVT 
human placental cell line HTR-8/SVneo.    
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Materials and Methods 
Chemicals and assay kits. BDE-47 was purchased from AccuStardard (New Haven, CT, USA). 
DMSO, deferoxamine mesylate (DFO), tert-butyl hydroperoxide (TBHP), cytochrome c from 
bovine heart, superoxide dismutase (SOD) from bovine erythrocytes, N-ethylmaleimide and 
rhodamine (Rh) 123, 4-hydroxy-TEMPO (tempol), and (±)-α-tocopherol were purchased from 
Sigma Aldrich (St. Louis, MO, USA). The 6-carboxy-dichlorodihydrofluorescein diacetate 
(carboxy-H2DCF-DA), CellMask
TM
 Deep Red plasma membrane stain C10046,  RPMI medium 
1640, fetal bovine serum (FBS), OptiMem 1 reduced-serum medium, Hank's balanced salt 
solution (HBSS), 0.25% trypsin/EDTA solution and penicillin/streptomycin (P/S) were 
purchased from Invitrogen Life Technologies (Carlsbad, CA, USA). Recombinant IL-1β and 
sandwich enzyme-linked immunosorbent assay (ELISA) kits for human IL-6, IL-8 were 
purchased from R & D systems (Minneapolis, MN, USA). The MultiTox-Glo Multiplex 
cytotoxicity assay kit was purchased from Promega (Madison, WI, USA).  QIAshredder, RNeasy 
mini plus kit, RT
2
 First Strand kit for reverse transcriptase reaction, RT
2
 qPCR SYBR 
Green/ROX Master Mix and primers for human β-microglobulin, IL-6, and IL-8 were purchased 
from Qiagen (Valencia, CA, USA).  BDE-47 was prepared in dimethyl sulfoxide (DMSO) as a 
50 mM stock solution. (±)-α-tocopherol was prepared in DMSO as a 100 mM stock solution. 
Rh123 was prepared in DMSO as a 2µg/ml stock solution. Carboxy-H2DCF-DA was prepared in 
DMSO as 50 mg/ml stock solution. Other chemicals were applied directly into media. 
Cell Culture and treatment.  The human first trimester extravillous trophoblast cell line HTR-
8/SVneo was kindly provided by Dr. Charles S. Graham (Queen's University, Kingston, ON, 
Canada). Cells between passages 71 and 84 were cultured in RPMI 1640 medium supplemented 
with 10% FBS and 1% penicillin/streptomycin  at 37°C in a 5% CO2 humidified atmosphere. 
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Cells were grown to a confluence of 70-90% before treatment. Cells were washed with OptiMem 
1 containing 1% FBS and 1% P/S twice and acclimated with the medium for 1 h at 37 °C. From 
solutions of 5, 10, 15 and 20 mM BDE-47 in DMSO, exposure media containing 5, 10, 15 and 
20 µM BDE-47 were made in OptiMem 1 containing 1% FBS and 1% P/S immediately prior to 
initiating the experiment. The final concentration of DMSO in medium was 0.7 % (v/v).  
Viability and Cytotoxicity Assays. Cells were seeded in a white 96-well plate at a density of 1 × 
10
4 
cells per well and incubated for 24 h at 37 °C. Cells were exposed to DMSO (solvent control) 
or BDE-47 (5, 10, 15 or 20 μM) and incubated for 24 h. After the 24-h incubation with BDE-47, 
cell viability and cytotoxicity were measured by the MultiTox-Glo Multiplex cytotoxicity assay 
kit. Briefly, this assay is based on two protease activities: one is a live-cell protease, and the 
other is a dead-cell protease, which is released from cells. Fluorescence is proportional to live 
cells while luminescence is proportional to dead cells. The assay was performed according to the 
manufacturer’s instructions. Digitonin (300 μg/ml) was used as a positive control.  
Dichlorofluorescein assay. Stimulation of ROS generation was assessed using the 
dichlorofluorescein (DCF) assay.  Because artifactual results can occur in the DCF assay due to 
interactions with toxicants (Tetz et al., 2013), we confirmed that there was no increased DCF 
fluorescence by BDE-47 in cell free medium (data not shown). The HTR-8/SVneo cells were 
seeded at a density of 2.4 × 10
5
cells per well in a 6-well plate and cultured for 24 h at 37 °C. 
Cells were pre-incubated in the presence or absence of 1 mM DFO for 1 h. Cells were washed 
once with Optimem1 medium containing 10 % FBS and 1% P/S, and then exposed to 5, 10, 15 
or 20 μM BDE-47 for 4 h. Treatment with 100 µM tert-butyl hydroperoxide (TBHP) was 
included as a positive control. After removal of the treatment and rinsing with HBSS, cultures 
were incubated for an additional 1 h with 100 μM carboxy-H2DCF-DA in HBSS. After removal 
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of the dye solution and rinsing with HBSS, cells were counterstained with 5 μg/ml CellMaskTM 
Deep Red plasma membrane stain for 5 min. After washing with HBSS and adding fresh HBSS 
back to the cultures, intracellular DCF fluorescence was visualized at 470 nm excitation and 525 
nm emission, and Deep Red stain was visualized at 530 nm excitation and 593 nm emission 
using an EVOS digital inverted fluorescence microscope. Five images per treatment were taken: 
one image in each of the four quadrants and one in the center of the well.  Equivalent 
adjustments for brightness and contrast were applied to each image in ImageJ software (National 
Institutes of Health). Additionally, fluorescence intensity was quantified using the method of He 
et al. (2008) with a few modifications. Cells exposed to BDE-47 were collected by treatment 
with 0.25% trypsin/EDTA solution for 2 min and washed twice with HBSS by centrifugation at 
1200 rpm for 3 min, then re-suspended in HBSS. After 1-h incubation with 100 μM carboxy-
H2DCF-DA in HBSS,  the fluorescence intensity of 200,000 cells in a 96-well, black, clear-
bottomed plate was measured using the Molecular Devices SpectraMax Gemini M2e at an 
excitation wavelength of 492 nm and emission wavelength of 522 nm. 
Cytochrome c reduction assay. Superoxide production in HTR-8/SVneo cells exposed to BDE-
47 was quantified by the cytochrome C reduction assay based on the method of Boota et al. 
(1996) with a few modifications. Superoxide production in HTR-/SVneo cells exposed to BDE-
47 was quantified by the cytochrome C reduction assay. HTR-8/SVneo cells were seeded at a 
density of 1 × 10
4 
cells per well in a white, clear bottomed, 96-well plate, and incubated for 24 h 
at 37 °C. Cells were exposed to 5, 10, 15 or 20 μM BDE-47 for 1 h. Pyrogallol (100 μM) was 
included as a positive control. Reaction buffer was prepared in HBSS with 70 μM 
ferricytochrome c with or without 80 μg/ml of SOD. After treatment with BDE-47, cells were 
washed once with HBSS and a 100 μl-aliquot of the reaction buffer solution was added to each 
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well of the plates. Cytochrome c reduction was measured at 550 nm after 10, 30, 60 and 90 min 
incubation with reaction buffer: results are shown for the 90-min time point because this was the 
reaction time that yielded maximal response. Superoxide production was determined based on 
the difference in cytochrome c reduction with or without SOD. An extinction coefficient of 28.0 
mM
-1
cm
-1 
was used for calculations. Results were expressed as nmoles superoxide released per 
1×10
4
 cells.  
Determination of the mitochondrial membrane potential (MMP). Rh123, which can bind 
specifically to mitochondria, was used to estimate MMP based on the methods of Yan et al. 
(2011)  with few modifications. HTR-8/SVneo cells were seeded at a density of 3 × 10
4 
cells per 
well in a black, clear bottomed, 96-well plate, and incubated for 24 h at 37 °C. Cells were 
exposed to 5, 10, 15 or 20 μM BDE-47 for 4, 8 or 24 h. Treated cells were washed once with 
HBSS and incubated with Rh123 (2.5 µg/ml) in HBSS for 60 min in the dark at 37 °C. After 
replacing Rh123 with fresh HBSS, the fluorescence was measured with a fluorescence 
spectrophotometer using 507 nm Ex and 529 nm Em filter settings. 
Measurement of cytokine release. The HTR-8/SVneo cells were seeded at a density of 2.4 × 
10
5
cells per well in a 6-well plate and cultured for 24 h at 37 °C. Cells were washed once with 
OptiMem1 medium containing 10 % FBS and 1% P/S and exposed to 5, 10, 15 or 20 μM BDE-
47 for 4, 8 or 24 h.  After incubation with BDE-47, culture medium was collected and 
centrifuged to remove any residual cell lysates. The concentration of IL-6 and IL-8 in the 
supernatant was measured by sandwich ELISA following the manufacturer’s protocols. To 
determine oxidative stress-mediated activation of inflammatory pathways by BDE-47, HTR-
8/SVneo cells were pretreated with 1 mM DFO for 1 h prior to BDE-47 treatment for 24 h, or co-
treated either with 20 µM (±)-α-tocopherol, a peroxyl radical scavenger, or with 1mM tempol, a 
37 
 
membrane-permeable SOD mimetic for 24 h. Concentrations of IL-6 and IL-8 in the medium 
was analyzed by ELISA as described above. Release of cytokines was expressed as pg/ml.  
RNA extraction and Quantitative real-time polymerase chain reaction. After 4, 12 or 24-h 
incubation with BDE-47, cell lysates were collected and homogenized using QIA shredder. Total 
RNA was extracted from homogenized lysates using RNeasy mini plus kit and cDNA was 
synthesized from 1μg of total RNA using RT2 First Strand Kit. The procedures were performed 
according to the instructions of the manufacturer. Quantitative real-time polymerase chain 
reaction (qPCR) was performed in a total volume of 25 μL containing 4 μL of cDNA template, 1 
μL of a gene-specific  primer (IL-6, IL-8, TNF-α, or IL-10), 12.5 μL of  RT2 SYBR Green qPCR 
Master Mix and 7.5 μL of nuclease-free H2O using  CFX96 Real-Time PCR Detection System 
(Bio-Rad Laboratories, Hercules, CA, USA). A housekeeping gene, β-microglobulin, was co-
amplified as an internal control. qRT-PCR was performed with an initial denaturation step of 10 
min at 95°C, followed by 40 cycles of 15 s at 95°C, 5 s at 60°C. At the end of each cycle, the 
fluorescence emitted by the SYBR Green was measured. After completion of the cycling process, 
samples were subjected to a temperature ramp (from 65°C to 95°C at 0.5°C/s) with continuous 
fluorescence monitoring for melting curve analysis. Signal intensities of target genes were 
quantified and normalized to the signal of β-microglobulin using Bio-Rad CFX manager 
software. The level of mRNA expression was presented as fold change compared to solvent 
controls. 
Statistical analysis. Statistical analysis was performed with Sigma Plot 11.0 software (Systat 
Software Inc., San Jose, CA, USA). Data were analyzed either by one-way analysis of variance 
(ANOVA) or repeated measured two-way ANOVA. If significant effects are detected, the 
ANOVA will be followed by Tukey post-hoc comparison of means. A P <0.05 was considered 
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statistically different. Data were expressed as means ± SEM. All experiments were repeated at 
least three times and all treatments were performed at least in triplicate in each experiment. 
Results 
Cytotoxicity of BDE-47  
To investigate the cytotoxic effect of BDE-47 on HTR-8/SVneo cells, protease-based viability 
and cytotoxicity assays were performed. Exposure to BDE-47 with concentrations up to 20 μM 
for 24 h did not result in a significant loss of cell viability in HTR-8/SVneo 8 cells as measured 
by cellular retention of proteases and indicated by sustained cellular fluorescence 
(Supplementary Figure 1A). In contrast, the loss of cell viability was clearly evident in cells 
treated with digitonin, included as a positive control. Similarly, cytotoxic effects were not 
significant with concentrations of BDE-47 up to 20 μM, as measured by increased luminescence 
due to protease release from dead cells, although digitonin-mediated cytotoxicity of HTR-
8/SVneo cells was apparent (Supplementary Figure 1B; P<0.05).  
Effect of BDE-47 on ROS production  
Treatment of HTR-8/SVneo cells with 20 μM BDE-47 for 4 h increased DCF fluorescence 
compared with solvent controls as visualized with epifluorescence microscopy, indicating 
increased carboxy-H2DCF-DA oxidation to the fluorescent DCF moiety, an indication of cellular 
reactive species generation (Figure 1A).  Pretreatment with the iron-chelating antioxidant DFO 
decreased BDE-47-stimulated DCF fluorescence (Figure 1A). There were no differences in 
fluorescence comparing cells from control cultures incubated in HBSS alone, HBSS with 0.7% 
DMSO, or HBSS with 1 mM DFO (data not shown). Quantification of the fluorescence intensity 
using a spectrophotometer showed that treatment with 20 μM BDE-47 induced 1.7-fold increase 
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in the DCF fluorescence in the HTR-8/SVneo cells (Table 1; P<0.05), which was inhibited by 
DFO pretreatment to the equivalent level of the solvent control (Table 2; P<0.05). There were no 
statistically significant differences between non-treated controls and solvent controls (Table 1 
and 2). 
Effect of BDE-47 on superoxide production  
BDE-47 treatment increased production of superoxide in HTR-8/SVneo cell cultures as 
measured with the cytochrome c reduction assay (Figure 2; P<0.05). Specifically,  superoxide 
production was 0.49, 0.5 and 0.93 nmoles/10
4
 cells in cells exposed to 10, 15, and 20 µM BDE-
47 for 1 h, significantly increased compared to the solvent control (Figure 2; P<0.05). Treatment 
with 100 µM pyrogallol, included as a positive control, increased ferricytochrome c reduction to 
2.19 nmoles/10
4
 cells, a significant increase compared to the solvent control and BDE-47-treated 
groups (Figure 2; P<0.05). The negative values detected in solvent controls with the cytochrome 
c reduction assay suggest oxidation of ferricytochrome c under our basal experimental 
conditions, as observed by others (Arthur et al., 1987).  
Changes in mitochondrial membrane potential (MMP) by BDE-47 treatment 
Because mitochondria are potential sources of cell-generated ROS, MMP was assessed by 
measuring fluorescence of Rh123, a dye specifically taken up by mitochondria in the normal 
polarized state. Treatment with 10, 15 and 20 µM BDE-47 significantly decreased Rh123 
fluorescence compared to solvent controls at 4, 8 and 24 h (Figure 3; P<0.05), indicating 
decreased MMP. Reduction in Rh123 fluorescence ranged from 47% to 65%, but was neither 
concentration-dependent nor time-dependent. The decrease of MMP was significant compared to 
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non-treated control, also, at 4 h with 20 µM BDE-47 and at 8 h with 10, 15, and 20 µM BDE-47 
(Figure 3; P<0.05). Treatment with 5 µM BDE-47 did not significantly change Rh123 
fluorescence at any time point up to 24 h. There were no statistically significant differences 
between non-treated controls and solvent controls at any time points. 
Effect of BDE-47 on cytokine production  
Because cytokines play critical roles in pregnancy (Keelan et al., 2003;  Orsi, 2008), we 
investigated the effect of BDE-47 on IL-6 and IL-8 production in HTR-8/SVneo cells. BDE-47 
treatment for 12 and 24 h stimulated concentration-dependent and time-dependent increases in 
IL-6 (Figure 4A; P<0.05) and time-dependent increases in IL-8 release (Figure 4B; P<0.05). 
Treatment with 15 or 20 μM BDE-47 significantly increased  IL-6 3.7- fold and 6.3- fold at 12 h, 
and 3.7-fold and 12-fold at 24 h, respectively, relative to the solvent control (Figure 4A; P<0.05). 
After 24 h, the lower concentration of 10 μM BDE-47 also induced a significant 1.9-fold 
increase of IL-6 compared to the solvent control (Figure 4A; P<0.05). Moreover, 15 and 20 μM 
BDE-47 treatment increased IL-6 release in a time-dependent manner from 12 h to 24 h (Figure 
4A; P<0.05). No statistically significant changes in IL-6 concentrations were observed with 4 h 
treatment at any BDE-47 concentration examined or with the lowest concentration evaluated, 5 
μM BDE-47, at any time point. Pro-inflammatory chemokine IL-8 concentrations in the medium 
was significantly increased after a 12-h treatment with 15 and 20 μM BDE-47 by 2.1-fold and 
2.3-fold, respectively, compared with solvent control (Figure 4B; P<0.05). In addition, 24-h 
treatment with 20 μM BDE-47 increased IL-8 release 1.8-fold compared with solvent control, to 
an average concentration that was significantly increased compared the average IL-8 
concentration observed after 12 h of exposure to 20 μM BDE-47 (Figure 4B; P<0.05). No 
statistically significant changes in IL-8 concentrations were observed with 4-h treatment at any 
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BDE-47 concentration examined or with 5 and 10 μM BDE-47 at any time point. There were no 
statistically significant differences between non-treated controls and solvent controls at any time 
point. 
Effect of BDE-47 on mRNA expression of cytokines in HTR-8/SVneo cells 
Expression of inflammatory cytokine genes in HTR-8/SVneo cells exposed to BDE-47 was 
quantified using real time qRT-PCR. Treatment with 15 and 20 µM BDE-47 for 12 h increased 
IL-6 mRNA expression by 14.7 fold and 35.4 fold, respectively, compared to the solvent control 
(Figure 5A; P<0.05).  Treatment with 20 µM BDE-47 for 24 h increased IL-6 mRNA 20.1 fold 
compared to the solvent control (Figure 5A; P<0.05).  Likewise, IL-8 expression increased with 
20 µM BDE-47 after 4, 12 and 24-h exposures compared to solvent control (Figure 5B; P<0.05). 
IL-8 mRNA expression increased with 12-h exposure to 15 and 20 µM BDE-47 by 12.1 fold and 
24.9 fold, respectively, compared with solvent control (Figure 5B; P<0.05). For both  IL-6 and 
IL-8, concentration-dependent increases in mRNA expression were observed with 15 and 20 µM 
at 12 h only. Treatment with 5 and 10 BDE-47 did not result in significant changes in IL-6 and 
IL-8 mRNA expression at any time point. Treatment with DMSO (solvent control) suppressed 
IL-8 mRNA expression at 12 h compared to non-treated control (Figure 5B, P<0.05). There were 
no other statistically significant differences between non-treated controls and solvent controls for 
IL-6 and IL-8 mRNA expression. 
Effect of Antioxidant treatment on BDE-47-stimulated cytokine production in HTR-8/SVneo 
cells 
To investigate the role of reactive oxygen species on BDE-47-mediated cytokine release in HTR-
8/SVneo cells, cells were pretreated with 1 mM DFO for 1 h prior to BDE-47 treatment for 24 h, 
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or co-treated with 20 µM (±)α-tocopherol for 24 h. As shown in Figure 6A, DFO pretreatment 
inhibited IL-6 release stimulated by 20 µM BDE-47 in HTR-8/SVneo cells, reducing IL-6 
release by 54.1% compared to cultures exposed to BDE-47 without DFO pretreatment (Figure 
6A; P<0.05). Although IL-6 concentrations in cultures pretreated with DFO prior to exposure to 
15 µM BDE-47 were not significantly reduced compared with cultures exposed to 15 µM BDE-
47 without DFO pretreatment, they also were not statistically significantly different from the 
non-treated or solvent controls. Similar to DFO, (±)α-tocopherol and tempol co-treatment for 24 
h resulted in 56.3% (relative to No Vehicle Control group, Figure 6B; P<0.05) and 37.7% 
(Figure 6C; P<0.05) reduction in BDE-47-mediated IL-6 production in HTR-8/SVneo cells. In 
the absence of (±)α-tocopherol cotreatment, a significant reduction in IL-6 release was observed 
for cultures  exposed to DMSO (0.7 % v/v) as the solvent control group for BDE-47 treatments  
compared to non-treated controls (Fig. 6B; P<0.05); however, there were no statistically 
significant differences between (DMSO) solvent and non-treated controls that also received the 
vehicle (DMSO 0.02% v/v) used with (±)α-tocopherol cotreatment (Fig. 6B). There were no 
significant changes in IL-8 production from HTR-8/SVneo cells with DFO pretreatment, (±)α-
tocopherol co-treatment, or tempol co-treatment (data not shown). 
 
Discussion 
Due to widespread use as flame-retardants in household and commercial products, human 
exposure to PBDEs increased exponentially over recent decades (Hites, 2004). Analysis of 2,062 
human serum samples from the NHANES 2003-2004 detected BDE-47 in nearly all participants, 
with BDE-47 having the highest concentration of the PBDE congeners measured (Sjodin et al., 
2008). Despite BDE-47 presence in human placental tissues (Frederiksen, et al., 2009;  Miller, et 
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al., 2009) and the importance of cytokine regulation in placental development during early 
pregnancy (Anton, et al., 2012), there are no previous reports of BDE-47-stimulated effects on 
inflammatory pathways in human first trimester placental cells. Moreover, we identified only a 
single previous report on PBDE-stimulated cytokine release in placenta with results showing that 
pre-exposure of second trimester human placental explant cultures to a PBDE mixture of congers 
47, 99 and 100 enhanced placental proinflammatory response to heat-killed E. Coli (Peltier, et 
al., 2012). The present study is distinct from the latter study in that we showed direct stimulation 
of proinflammatory cytokines in the absence of pathogen exposure in a first trimester human 
extravillous trophoblast cell line treated with a single BDE congener. 
 Oxidative stress has been suggested to play a role in human pregnancy-related disorders, 
such as preterm labor, preeclampsia, and IUGR (Agarwal, et al., 2012). The present study 
provides new information that BDE-47 increased ROS generation in the human trophoblast cell 
line HTR-8/SVneo. Moreover, BDE-47 decreased mitochondrial membrane potential, indicating 
mitochondrial dysfunction (Brand and Nicholls, 2011). Because mitochondrial defects can lead 
to enhanced mitochondrial production of ROS and superoxide is a major type of ROS generated 
by mitochondrial respiration (Sohal et al., 1995), we suggest that the BDE-47-stimulated 
superoxide production in HTR-8/SVneo cells may have originated from mitochondria. 
Superoxide also acts as a precursor for formation of other types of ROS (Al-Gubory et al., 2010). 
As such, the increased DCF fluorescence observed with BDE-47 could be explained by 
subsequent formation of peroxyl, hydroxyl radical and other ROS from mitochondrial 
superoxide. However, our findings are correlative only and require further research to confirm 
the present findings and to elucidate our mechanistic hypothesis.  
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 Similar to our results with HTR-8/SVneo cells, BDE-47-stimulates intracellular ROS 
formation in rat neuronal cells (He, et al., 2008), Jurkat cells (Yan, et al., 2011), human fetal 
liver hematopoietic stem cells (Shao, et al., 2008), and human neutrophil granulocytes (Reistad 
and Mariussen, 2005a). In contrast to previously reported studies that BDE-47 induces apoptosis 
in Jurkat cells (Yan, et al., 2011) and human fetal liver hematopoietic stem cells (Shao, et al., 
2008), we observed no significant loss of cell viability in HTR-8/SVneo cells after a 24-h 
treatment with BDE-47 (Supplementary Figure 1). A possible explanation for these 
inconsistencies is that the range of BDE-47 concentrations used in our study (5-20 µM) was 
much lower than concentration ranges used in studies reporting BDE-47-induced cytotoxicity 
and/or a mitochondrial membrane potential reduction: 25-100 µM (Yan, et al., 2011) and 50 µM 
(Shao, et al., 2008). Moreover, different types of cells (human trophoblasts versus rat neuronal 
cells, Jurkat cells, human fetal liver hematopoietic stem cells, or human neutrophil granulocytes) 
and experimental conditions (media, serum concentration, exposure duration, cell density, etc.) 
may generate divergent responses to the same chemical. Notably, our study provides the first 
evidence that BDE-47 decreases mitochondrial membrane potential at lower concentrations of 
BDE-47 (10, 15 and 20 µM) than reported previously.  
Treatment with BDE-47 reduced mitochondrial membrane potential, though the observed 
reduction was not concentration-dependent for the BDE-47 concentration range examined (10, 
15, and 20 µM). The lack of a concentration-dependent reduction in mitochondrial membrane 
potential could be explained by the narrow range of BDE-47 concentrations in our studies, 
especially if the sensitivity of Rh123 may not be sufficient to detect the differences in 
mitochondrial membrane potential within this range of concentrations. Similar to our findings, 
Yan et al. (2011) did not show a concentration-dependent decrease in mitochondrial membrane 
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potential in BDE-47-treated Jurkat cells with 5, 10 and 25 µM BDE-47 using Rh123, although a 
decreasing trend was observed as concentrations increased up to 100 µM. Shao et al.(2008) also 
reported a decrease in mitochondrial membrane potential in human fetal liver hematopoietic stem 
cells at 12.5 and 50 µM using another mitochondria-specific dye, JC-1, but did not show a 
significant concentration-dependent reduction, either. Further study using an expanded range of 
BDE-47 concentrations will be needed to clarify reasons for the lack of a concentration-
dependent effect on the mitochondrial membrane response. 
 Little is known about interactions of BDE-47 with the innate immune response. It was 
recently reported that BDE-47-pretreatment of peripheral blood mononuclear cells from children 
with autism spectrum disorders exhibit divergent LPS-stimulated innate cytokine responses 
compared with age-matched controls (Ashwood et al., 2009).  Peltier  et al. (2012) reported that 
pre-exposure of placental explants to a PBDE mixture of congers 47, 99 and 100 enhanced 
placental proinflammatory response to heat-killed E. Coli, with increased IL-1β and reduced IL-
10 production. In the latter study by Peltier et al.(2012), however, PBDE treatment alone did not 
stimulate proinflammatory cytokine production in placental explant cultures. We observed that 
BDE-47-stimulated cytokine mRNA expression increased for IL-8 as early as 4 h with 20 µM 
exposure, then peaked 12 h after initiating exposure, the only time point in our study where we 
observed significantly increased IL-6 and IL-8 mRNA expression at the lower concentration of 
15 µM, also. Compared with mRNA expression, cytokine protein release lagged temporally, 
with initial increases after 12 h and further increases after 24 of exposure to BDE-47.  The lowest 
effective concentration for cytokine response was observed with 10 µM BDE-47-stimulated 
increase of IL-6 protein after 24 h of exposure. As such, our study is the first to report direct 
effect of BDE-47 on regulation of cytokine production in human placental cells, showing that 
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BDE-47 increased proinflammatory IL-8 and IL-6 in HTR-8/SVneo cells at the transcriptional 
and protein levels. Moreover, the BDE-47-stimulated increased mRNA levels of IL-6 and IL-8, 
suggesting that activation of transcription contributes to the overall increased cytokine 
expression. Because the fold change in cytokine protein production was modest compared to the 
fold change in cytokine mRNA expression, additional post-transcriptional mechanisms may 
modulate protein expression (Griesinger et al., 2001;  Wang et al., 2011;  Ye et al., 2011).  
 Inflammation within the gestational compartment may lead to impaired trophoblast 
cellular function, contributing to the placental dysfunction seen in pregnancy-related disorders. 
Histologic examination found evidence of localized inflammation (histologic chorioamnionitis) 
in 85% of placentae from spontaneous preterm births delivered at 28 weeks gestation (Yoon et 
al., 2000) with higher rates of placental ischemia and abnormal placentation compared with 
controls at term (Germain, et al., 1999;  Kim, et al., 2003). A recent study reported that LPS 
increases production of IL-8 and IL-6 and decreases invasion activity in HTR-8/SVneo cells 
(Anton, et al., 2012). Our study showed that exposure to BDE-47 stimulated pro-inflammatory 
IL-6 and IL-8 production in HTR-8/SVneo cells, suggesting that BDE-47 could potentially 
impair normal trophoblast cellular function and invasion. However, we did not measure BDE-47 
effects on trophoblast invasion, and further investigation is needed to ascertain the potential 
relevance of BDE-47 exposure to placental function and pregnancy.  
 It has been reported that ROS can regulate signal transduction pathways in mammalian 
cells as second messengers (Khan and Wilson, 1995). Our study clearly showed the novel 
finding that ROS play a role in activation of BDE-47-mediated inflammatory response in HTR-
8/SVneo cells. Three different antioxidant treatments suppressed BDE-47-stimulated IL-6 
production in HTR-8/SVneo cells. Although mechanisms of regulation of inflammatory response 
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by ROS are not fully understood, involvement of the redox-sensitive transcription factor NF-κB 
has been implicated (Reuter, et al., 2010). NF-κB plays a crucial role in immune and 
inflammatory response, regulating gene expression of a large number of genes, including 
cytokines, growth factors, adhesion molecules, immunoreceptors, and acute-phase proteins 
(Blackwell and Christman, 1997). Several lines of evidence suggest a role for ROS in activation 
of NF-κB, and antioxidants inhibit NF-κB activation in vitro and in vivo (Blackwell and 
Christman, 1997). Moreover, NF-κB plays a crucial role in the transcription of IL-6 and IL-8 
(Blackwell and Christman, 1997;  Reuter, et al., 2010). Although we did not assess BDE-47-
induced NF-κB activation in HTR-8/SVneo cells, we speculate that NF-κB may be involved in 
BDE-47-stimulated cytokine production in HTR-8/SVneo cells because both cytokines were 
notably increased with BDE-47 treatment.  
 The mechanisms of PBDE toxicity have not been fully resolved. Because of the similar 
chemical structures of PBDEs and their metabolites to thyroid hormones, polychlorinated 
biphenyls (PCBs), and 2,3,7,8-tetra- chlorodibenzo-p-dioxin (TCDD) (Ren and Guo, 2013),  
other studies have focused on PBDEs' toxic effects through nuclear hormone receptor (NR) 
mediated pathways involving thyroid hormone receptor (TR), estrogen receptor (ER), aryl 
hydrocarbon receptor (AhR), androgen receptor (AR) and progesterone receptor (PR) 
(Ibhazehiebo et al., 2011;  Kojima et al., 2009;  Mercado-Feliciano and Bigsby, 2008) (Liu et al., 
2011;  Ren and Guo, 2013;  Stoker et al., 2005). For example, hydroxylated BDE-47 metabolites 
showed modest binding potency with rat TR (Kitamura et al., 2008) whereas BDE-199, 153, 
154, 209  and DE-71 (a commercial PBDE mixture) showed antagonistic activity for TRβ in CV-
1 monkey fibroblast-derived cells (Ibhazehiebo, et al., 2011). BDE-47 showed agonistic 
activities in the ERα and ERβ by the ER-CALUX assay using Chinese hamster ovary cells 
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(Kojima, et al., 2009). Chen et al. (2001)  reported that 18 PBDE congeners and 3 commercial 
mixtures bound to rat hepatic AhR with affinities 10
-2
 to 10
-5
 times that of TCDD. Anti-
androgenic activity of PBDEs also has been observed (Kojima, et al., 2009;  Liu, et al., 2011). 
Although these studies suggest potential roles of NRs on endocrine disruption by PBDEs, the 
contribution of NR activation to BDE-47-stimulated inflammatory responses in the present study 
is not clear. It was recently suggested that NRs regulate inflammatory pathways by altering the 
turnover or recruitment of co-repressors and co-activators in a gene-specific manner. These NR-
dependent trans-repression pathways may play roles in controlling the initiation, magnitude and 
duration of pro-inflammatory gene expression (Glass and Saijo, 2010;  Huang and Glass, 2010). 
However, further study on the biological mechanisms of action of PBDEs is warranted to 
investigate roles of potential receptors and mediators in the activation and regulation of BDE-47 
mediated inflammation in human placental cells.  
 In the present study, we used DMSO at a final concentration of 0.7% to deliver BDE-47 
to the cell cultures. Although previous reports used lower DMSO concentrations to deliver 
similar or higher concentrations of BDE-47 to cell cultures (Shao, et al., 2008;  Yan, et al., 
2011), we found that BDE-47 precipitated out over time in cultures at final DMSO 
concentrations below 0.7% in our laboratory. DMSO is widely used as a vehicle for hydrophobic 
pharmaceutical agents in biomedical research. In preliminary experiments, we evaluated 1,4-
dioxane as an alternative vehicle for BDE-47, but decided on using DMSO because BDE-47 had 
better solubility  in DMSO and because DMSO is more commonly used in cell culture studies 
with PBDEs. However, DMSO’s reported antioxidant and anti-inflammatory properties raise 
cautions when interpreting results from studies using DMSO as a solvent. It has been reported 
that DMSO (≥1% v/v) is a strong antioxidant that scavenges hydroxyl free radicals (Bektasoglu 
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et al., 2006;  Halliwell et al., 1987;  Panganamala et al., 1976), and reduces production of 
hydroxyl radicals, lipid peroxidation, and protein carbonyl formation (Sanmartin-Suarez et al., 
2011). DMSO also exhibits anti-inflammatory properties by inhibiting secretion and/or mRNA 
expression of pro-inflammatory mediators such as TNF-α, IL-6, and IL-8, by decreasing 
prostaglandinE2 production related to COX-2 activity,  and by reducing  NF-κB activation in in 
vivo and in vitro (Chang et al., 1999;  DeForge et al., 1992;  Hollebeeck et al., 2011;  Kelly et 
al., 1994;  Nakamuta et al., 2001). Although means of solvent controls and non-treated controls 
had divergent values in most experiments in the present study, statistically significant differences 
between these control groups were detected only in experiments measuring IL-8 mRNA 
expression and IL-6 protein. Preliminary data prior to this study showed that treatment of HTR-
8/SVneo cells with higher DMSO concentrations (0.75-1%) suppressed BDE-47-stimulated IL-6 
release in a concentration-dependent manner (Supplementary Figure 2). Because DMSO effects 
were in the opposite direction than the observed BDE-47-stimulated effects, it is likely that any 
confounding by DMSO on IL-6 release would result in muting the IL-6 response, making it more 
difficult to observe significant increases. We clearly show that BDE-47 stimulated ROS 
overproduction and inflammatory responses in HTR-8/SVneo cells, outweighing possible 
opposing DMSO effects. We suggest that the DMSO effects on cytokine production are due to 
its radical scavenger or anti-inflammatory properties. However, it is out of the scope of the 
present work to clarify the mode of actions of DMSO in cytokine production because DMSO 
was used purely as a vehicle control in this investigation. 
 A limitation of our study is that overproduction of IL-6 and IL-8 alone may not 
accurately represent the proinflammatory response and the possible impact of BDE-47 exposure 
on trophoblast cellular function in vivo. Although changes in cytokine levels by an activated 
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immune response play an important role in regulating trophoblast function, there are complex 
interactions between cytokines and trophoblast invasion involving other pro- and anti-invasive 
factors, such as other cytokines/chemokines, integrins, and adhesion and proteolytic molecules 
(Anton, et al., 2012).  
The concentrations of BDE-47 in this study are several orders of magnitude higher (100-
fold or more) than the median concentrations reported previously in utero and placenta: 337 - 
21842 pg/ml in amnionic fluid (Miller, et al., 2012), 0.11- 3000 ng/g lipid in placentae (Doucet 
et al., 2009;  Frederiksen, et al., 2009), and 0.46 to 504 ng/g lipid in umbilical cord blood 
(Frederiksen, et al., 2009;  Guvenius et al., 2003;  Wu, et al., 2010). However, PBDE 
concentrations vary markedly among samples and can differ by three orders of magnitude, 
possibly due to factors such as proximity to the source of contamination, length of exposure, 
individual life style, occupation, nutritional status, absorption, metabolism, and excretion 
(Athanasiadou et al., 2008;  Doucet, et al., 2009;  Gill et al., 2004;  Stapleton et al., 2008). 
Taking this variability of exposure into consideration and assuming that the lipid content in 
placentae is 1.31%, the concentrations of PBDEs in placentae can be as high as ~8 µM (Doucet, 
et al., 2009). Moreover, correcting for adsorption onto plastic, estimated at 73% (Barber et al., 
2006;  Mundy et al., 2004), the corrected concentrations of BDE-47 in culture medium in this 
study range from 1.34 to 5.4 µM. In addition, we have not examined the effect of multiple or 
chronic exposures to PBDEs, and it is unlikely for people to be exposed to a single PBDE 
congener like BDE-47 (Shao, et al., 2008).  Moreover, some PBDE congeners showed the ability 
to act synergistically when combined (Tagliaferri et al., 2010) or with other toxicants (Fischer et 
al., 2008;  Pellacani et al., 2012).  Ongoing research in our laboratory on the effects of other 
prevalent PBDE congeners, such as BDE-49 and 99, will lead us toward a better understanding 
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of the mechanisms and relevant risks associated with PBDE exposures in gestational 
compartments. Moreover, ongoing analysis of gene expression array data is expected to guide us 
in future experiments to elucidate the mechanisms of BDE-47-stimulated ROS formation and 
cytokine production.  
In summary, BDE-47, a predominant flame retardant chemical found in human tissues, 
activates proinflammatory responses in human first trimester EVTs. Our results provide evidence 
of altered mitochondrial membrane potential, enhanced production of ROS, and enhanced 
production of the proinflammatory cytokines IL-6 and IL-8 stimulated by BDE-47 in human 
placental cells. The inhibition of stimulated release of IL-6 by a variety of antioxidant treatments 
implicates the involvement of ROS in regulation of cytokine production in HTR-8/SVneo cells. 
This is the first study to show that BDE-47 activates proinflammatory pathways in human first 
trimester EVTs and to link PBDE-stimulated pro-inflammatory responses with ROS. Because 
proper trophoblast function is necessary for placental development and successful pregnancy, 
further investigation of the impact of BDE-47 on trophoblast function is warranted. 
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Table 2.1. Quantification of BDE-47-Stimulated ROS Production in HTR-8 cells
a 
 
Treatment DCF fluorescence intensity 
NT                   174.60 ± 8.17 
Solvent control                   183.10 ± 12.36 
 5 µM BDE-47                   257.50 ± 23.77 
10 µM BDE-47                   260.60 ± 25.88 
15 µM BDE-47                   247.40 ± 27.36 
20 µM BDE-47                   309.10 ± 16.72* 
100 µM TBHP  555.00 ± 109.40* 
 
a
 HTR-8 cells were non-treated (NT; control), or were treated with DMSO (solvent control), 
BDE-47 or tert-butyl hydroperoxide (TBHP, positive control) for 4 h, then loaded with carboxy-
H2DCF-DA for 1 h. Values represent the means ± SE of 3 independent experiments containing 4 
replicates each. *P<0.05, significant compared to solvent control. 
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Table 2.2.  Inhibition of BDE-47-Stimulated ROS Production by Antioxidant Pretreatment in 
HTR-8 cells
b
 
Treatment 
DCF Fluorescence Intensity 
No DFO 1mM DFO 
NT 216.30 ± 7.71 218.80 ± 5.71 
Solvent control 216.70 ± 7.53 215.60 ± 6.96 
20 µM BDE-47  279.60 ± 8.98*  215.40 ± 6.98# 
 
b
 HTR-8 cells were pretreated for 1 h with or without deferoxamine mesylate (DFO) prior to 
exposure to non-treated control (NT), DMSO (solvent control) or BDE-47 for 4 h, and then 
loaded with carboxy-H2DCF-DA for 1 h. Values represent the means of 3 independent 
experiments containing 4 replicates each ± SE. *P<0.05, significant compared to solvent control. 
#P<0.05, significantly different compared to non-DFO treated group.  
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Figure 2.1. Fluorescence microscopy visualization of BDE-47-stimulated dichlorofluorescein 
(DCF) fluorescence, an index of reactive oxygen species production, in a first trimester human 
extravillous trophoblast cell line, HTR-8/SVneo.  
HTR-8/SVneo cells were pretreated for 1 h with or without 1 mM deferoxamine mesylate (DFO), 
and then received no further treatment (NT, non-treated control) or were exposed to DMSO 
(solvent control), 20 µM BDE-47 or 100 µM tert-butyl hydroperoxide (TBHP; positive control) 
for 4 h. Subsequently, the cells were loaded with the non-fluorescent pro-dye carboxy-H2DCF-
DA for 1 h, counterstained with CellMask
TM
 Deep Red plasma membrane dye, and 
photographed using an epifluorescence microscope. The top panel shows representative images 
of intracellular DCF fluorescence, and the bottom panel show corresponding Deep Red 
membrane staining. Representative images of 3 independent experiments.  
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Figure 2.2. BDE-47-induced cytochrome c reduction, an index of superoxide anion production, 
in HTR-8/SVneo cells.  
HTR-8/SVneo cells were treated for 1 h with DMSO (solvent control) or BDE-47, then 
incubated with cytochrome c reaction buffer with or without SOD for 90 min. Bars represent the 
means of 3 independent experiments containing 6 replicates each ±SE. *P<0.05, significant 
compared to solvent control. 
#
P<0.05, significant compared to 5, 10, 15, and 20 µM BDE-47. 
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Figure 2.3. BDE-47 effects in HTR-8/SVneo cells on mitochondrial membrane potential (MMP).  
HTR-8/SVneo cells were treated for 4, 8 or 24 h with non-treated control (NT), DMSO (solvent 
control) or BDE-47, and then loaded with Rh123 for 1 h. Bars represent the means of 6 
independent experiments containing 4 replicates each ±SE. *P<0.05, significant compared to 
solvent control within same time point. 
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Figure 2.4.  BDE-47-induced pro-inflammatory cytokine production in HTR-8/SVneo cells. 
HTR-8/SVneo cells were untreated (NT, non-treated control), or treated for 4, 8 or 24 h with 
DMSO (solvent control) or BDE-47, and then concentrations of IL-6 (A) and IL-8 (B) in culture 
medium were quantified by EIA.  Bars represent the means ± SE of 3 independent experiments 
containing 3 replicates each. *P<0.05, significant compared to solvent control within same time 
point.
 #
P<0.05, significant compared to same treatment at12 h. 
+
P<0.05, significantly different 
from next lowest concentration within time point. 
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Figure 2.5. BDE-47 effects on mRNA expression of inflammatory cytokine genes in HTR-
8/SVneo cells.   
HTR-8/SVneo cells were treated for 4, 8 or 24 h with non-treated control (NT), DMSO (solvent 
control) or BDE-47. The mRNA expression of IL-6 (A) and IL-8 (B) was quantified by qRT-
PCR. Bars represent the means ± SE of 3 independent experiments containing 3 replicates each. 
*P<0.05, significant compared to solvent control within same time point. 
#
P<0.05, significantly 
different from next lowest concentration within time point. 
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Figure 2.6. Effects of antioxidant treatments on BDE-47-stimulated IL-6 release in HTR-
8/SVneo cells. 
 HTR-8/SVneo cells receiving antioxidant treatments were pretreated with DFO for prior to 
exposure to had no further treatment (non-treated control, NT), or were exposed to DMSO 
(solvent control), 15 µM BDE-47 or 20 µM BDE-47, or were co-treated with (±)-α-tocopherol or 
tempol. A) Effects of 1-h pretreatment with DFO on BDE-47-stimulated IL-6 release. B) Effects 
of (±)-α-tocopherol cotreatment on BDE-47-stimulated IL-6 release; vehicle controls were 
exposed to DMSO (used to deliver (±)-α-tocopherol, 0.02% v/v) and additional controls received 
no vehicle. C) Effects of tempol cotreatment on BDE-47-stimulated IL-6 release. Bars represent 
the means ± SE of 3 independent experiments containing 3 replicates each. *P<0.05, significant 
compared to respective solvent controls. 
&
P<0.05, significant compared to 15 µM BDE-47-
treated group. 
#
P<0.05, significantly different from each other. 
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Appendix 2.1. BDE-47 effects in HTR-8/SVneo cells on A) cytotoxicity and B) cell viability 
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Appendix 2.2. DMSO effects in HTR-8/SVneo cells on BDE-47-stimulated IL-6 release. 
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 PROTECTIVE EFFECT OF (±)α-TOCOPHEROL ON CHAPTER 3.
BDE-47-STIMULATED PROSTAGLANDIN PATHWAYS IN 
HUMAN EXTRAVILLOUS TROPHOBLASTS IN VITRO 
 
Abstract 
Polybrominated diphenyl ethers (PBDEs) are widely used flame retardant compounds. 
Brominated diphenyl ether (BDE)-47 is one of the most prevalent PBDE congeners found in 
human breast milk, serum and placenta. Exposure to BDE-47 has been linked to adverse 
pregnancy outcomes in humans including preterm birth, low birth weight and stillbirth. Although 
the underlying mechanisms of adverse birth outcomes are poorly understood, critical roles of 
prostaglandin pathways are implicated. The present study investigates BDE-47- activation of 
prostaglandin pathways in a human extravillous trophoblast cell line, HTR-8/SVneo. In addition, 
the role of the peroxyl radical scavenger (±)-α-tocopherol on the regulation of prostaglandin 
production was evaluated. HTR-8/SVneo cells were treated with BDE-47 in the presence or 
absence of (±)-α-tocopherol for 24 h. Then, prostaglandin E2 (PGE2) release was measured 
using enzyme-linked immunesorbant assay. mRNA expression of prostaglandin-endoperoxide 
synthase 2 (PTGS2), prostaglandin E synthase (PTGES), and 15-hydroxyprostaglandin 
dehydrogenase (HPGD) was quantified by qRT-PCR. Protein expression of COX-2 and 
prostaglandin E synthase (PGES) was measured by western blot. At 24 h, 20 μM BDE-47 
induced significant increases in PGE2 concentration in the culture medium, suggesting increased 
COX activity. The PGE2 increases were accompanied by significant 5.3, 4.4 and 4.7-fold 
increases in mRNA expression of PTGS2 at 4, 12 and 24 h, respectively. Furthermore, treatment 
with 15 and 20 μM BDE-47 significantly decreased mRNA expression of PTGES and HPGD. 
Treatment with 20 μM BDE-47 for 24 h induced a significant 2.0-fold increase in COX-2 
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expression. (±)-α-Tocopherol  cotreatment suppressed BDE-47-stimulated increases of  PGE2 
without affecting COX-2 mRNA and protein expression, implicating post-translational 
regulations of COX activity by (±)-α-tocopherol. Because abnormal activation of prostaglandin 
production can disrupt trophoblast functions that are necessary for placental development and 
successful pregnancy, further investigation is warranted of the impact of BDE-47 on trophoblast 
cellular responses. 
Introduction 
Proper placental development is prerequisite for a successful pregnancy. Abnormal 
placentation contributes to the pathophysiology of adverse obstetrical complications such as 
preeclampsia (Brosens, 1977;  Gerretsen et al., 1981;  Robertson et al., 1967;  Sheppard and 
Bonnar, 1976), intrauterine growth restriction (IUGR) (Gerretsen, et al., 1981;  Hustin et al., 
1983;  Labarrere and Althabe, 1987;  Sheppard and Bonnar, 1981), spontaneous abortion (Hustin 
et al., 1990;  Khong et al., 1987), preterm premature rupture of membranes (Kim et al., 2002),  
and preterm birth (Kim et al., 2003). Although the mechanisms responsible for improper 
placentation have not been fully elucidated, the role of impaired trophoblast invasion has been 
implicated (Zhou et al., 1997). The extravillous trophoblasts (EVTs) are a highly proliferative 
and migratory cell population that invades  the decidual and myometrial segments of the spiral 
arteries, resulting in the reversible remodeling of the normal arterial wall architecture (Anton et 
al., 2012;  Brosens et al., 1967;  Pijnenborg et al., 1983;  Pijnenborg et al., 1980). Trophoblast 
invasion is tightly regulated by a number of autocrine and paracrine factors including growth 
factors, growth factor-binding proteins, and proteoglycans (Chakraborty et al., 2002;  Lala and 
Chakraborty, 2003). Recently, inflammatory mediators such cytokines and prostaglandins have 
been shown to play a role in the regulation of trophoblast function during first trimester of 
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pregnancy (Biondi et al., 2006;  Horita et al., 2007a;  Jovanovic et al., 2010;  Jovanovic and 
Vicovac, 2009;  Nicola et al., 2005b).  
Prostaglandins are small lipid inflammatory molecules synthesized from membrane 
phospholipids in response to various physiological and pathological stimuli (Nicola, et al., 
2005b). Of these, prostaglandin E2 (PGE2) is one of the most extensively studied prostaglandins, 
and has been shown to play critical roles in successful pregnancy, for example in  implantation 
(Psychoyos et al., 1995;  Yee et al., 1993), immunoprotection of the semiallogenic conceptus 
(Parhar et al., 1988), and parturition (Keelan et al., 2003). PGE2 is produced by a series of 
biochemical reactions invoving conversion of arachidonic acid to PGH2 by cyclooxygenase 
(COX)-1 and COX-2 (Jakobsson et al., 1999;  Kuroda and Yamashita, 2003;  Stichtenoth et al., 
2001), followed by PGH2 metabolism to PGE2 by PGE2 synthase (PGES) (Horita, et al., 
2007a). PGE2 can be catabolized further to the biologically inactive keto-metabolites by 15-
hydroxyprostaglandin dehydrogenase (HPGD) (Tai et al., 2006). Dysregulation of PGE2 
production within the gestational compartment has been linked to adverse birth outcomes such as 
intrauterine growth restriction, preeclampsia and preterm birth (Germain et al., 1999;  Ness and 
Sibai, 2006). Although it is not fully understood how dysregulated prostaglandin pathways lead 
to these adverse impacts, it is suggested that PGE2 regulates trophoblast cellular functions that 
are critical for successful placentation (Biondi, et al., 2006;  Horita et al., 2007b;  Nicola et al., 
2005a).   
Polybrominated diphenyl ethers (PBDEs) are commercially produced synthetic flame-
retardants that have been used in textiles, plastics, building materials and insulation (Miller et al., 
2009b). Among the 209 PBDE congeners, BDE-47 (2,2′,4,4′-tetra-BDE) is one of the most 
prevalent congers found in human tissues and environmental samples (Hites, 2004). Because of 
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PBDEs’ environmental persistence and toxicity, the US EPA has identified PBDEs as a priority 
human health concern (U.S. Environmental Protection Agency, 2006). Limited studies report 
reproductive toxicity of PBDEs during pregnancy. Rabbits orally exposed to PBDEs showed 
decreased gestation length (Breslin et al., 1989). In human studies, Main et al. reported a 
significantly higher risk of cryptorchidism for sons born to mothers with elevated PBDE levels in 
breast milk (Main et al., 2007). In addition, Chao et al. found that elevated levels of PBDEs in 
breast milk correlated with decreased infant birth weight, infant birth length, infant chest 
circumference and infant body mass index (Chao et al., 2007). Elevated levels of PBDEs in 
human umbilical cord blood have been correlated with preterm birth, low birth weight or 
stillbirth (Wu et al., 2010). Although these studies report associations between PBDE exposure 
and adverse birth outcomes, and although PBDEs distribute to human placenta (Frederiksen et 
al., 2009), extraplacental membranes (Miller et al., 2009a), amniotic fluid (Miller et al., 2012), 
and umbilical cord blood (Frederiksen, et al., 2009), studies of mechanisms by which PBDEs act 
on gestational tissues during pregnancy are limited. Specifically, we identified one study 
reporting that pre-exposure of placental explants to a PBDE mixture of congers 47, 99 and 100 
enhanced placental pro-inflammatory response to heat-killed E. Coli, with increased PGE2 
release and COX-2 expression (Peltier et al., 2012).  
Our previous study showed that treatment with BDE-47 stimulated production of reactive 
oxygen species in in the first trimester EVT human placental cell line HTR-8/SVneo (Park et al., 
2014).  Increased oxidative stress in placenta, possibly due to increased generation of ROS,  has 
been observed in pathological pregnancies, and ROS have been implicated in the activation of 
inflammatory responses in gestational compartments (Buhimschi et al., 2003;  Cindrova-Davies 
et al., 2007). Moreover, formation of reactive oxygen species (ROS) has been shown to modulate 
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pathways in various experimental models (Basu, 1999;  Davidge, 1998;  Gonzalez et al., 2000;  
Wentzel et al., 1999). The present study examines the hypothesis that BDE-47 stimulates PGE2 
production via a ROS-mediated mechanism in the first trimester EVT human placental cell line 
HTR-8/SVneo. 
Materials and Methods 
Chemicals and assay kits. BDE-47 was purchased from AccuStandard (New Haven, CT, USA). 
Dimethyl sulfoxide (DMSO), tert-butyl hydroperoxide (TBHP), indomethacin, NS398, and (±)-
α-tocopherol were purchased from Sigma Aldrich (St. Louis, MO, USA). Purchase of 6-carboxy 
dichlorodihydrofluorescein diacetate (carboxy-H2DCF-DA), Hoechst 33342 dye, RPMI medium 
1640, fetal bovine serum (FBS), OptiMem 1 reduced-serum medium, Hank's balanced salt 
solution (HBSS), 0.25% trypsin/EDTA solution and penicillin/streptomycin (P/S) was from 
Invitrogen Life Technologies (Carlsbad, CA, USA).  PGE2 ELISA kit and arachidonic acid was 
purchased from Cayman Chemical (Ann Arbor, MI, USA QIAshredder, RNeasy mini plus kit, 
RT
2
 First Strand kit for reverse transcriptase reaction, RT
2
 qPCR SYBR Green/ROX Master 
Mix, and primers for human β-microglobulin, PTGS2, PTGES and HPGD were purchased from 
Qiagen (Valencia, CA, USA). IGEPAL The NP-40 substitute, CA-630 was purchased from 
United States Biological (Salem, MA). PhosStop protease inhibitor cocktail and complete mini 
protease inhibitor cocktail tablets were from Roche (Indianapolis, IN). Reducing Laemmli SDS 
sample buffer was purchased from Boston BioProducts (Ashland, MA). Memcode reversible 
protein staining kit and bicinchoninic acid (BCA) assay kit were from Thermo Scientific 
(Waltham, MA). Alkaline phosphatase-linked secondary antibody was purchased from Cell 
Signaling Technology (Beverly, MA). Enhanced chemifluorecence (ECF) substrate and PVDF 
membrane Hybond-P were purchased from GE Healthcare Life Sciences (Pittsburgh, PA).  
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Cell Culture and treatment.  The human first trimester extravillous trophoblast cell line HTR-
8/SVneo was kindly provided by Dr. Charles S. Graham (Queen's University, Kingston, ON, 
Canada). Cells between passages 71 and 84 were cultured in RPMI 1640 medium supplemented 
with 10% FBS and 1% penicillin/streptomycin  at 37°C in a 5% CO2 humidified atmosphere. 
Cells were grown to 70-90% confluence before treatment. Cells were washed twice with 
OptiMem 1 containing 1% FBS and 1% P/S, and then acclimated with the medium for 1 h at 37 
°C. From solutions of 20 mM BDE-47 in DMSO, exposure media containing 20 µM BDE-47 
were made in OptiMem 1 containing 1% FBS and 1% P/S immediately prior to initiating the 
experiment. The final concentration of DMSO in medium was 0.7 % (v/v).  
Dichlorofluorescein assay. Stimulation of ROS generation was assessed using the 
dichlorofluorescein (DCF) assay. Because artifactual results can occur in the DCF assay due to 
interactions with toxicants (Tetz et al., 2013), we confirmed that there was no increased DCF 
fluorescence by BDE-47 in cell free medium (data not shown).The HTR-8/SVneo cells were 
seeded at a density of 2.4 × 10
5
cells per well in a 6-well plate and cultured for 24 h at 37 °C. 
Cells were washed once with OptiMem 1 medium containing 1% FBS and 1% P/S, and then 
were untreated (NT, non-treated controls), or exposed to solvent control (DMSO 0.7% v/v), 15 
μM BDE-47 or 20 μM BDE-47 for 4 h in the absence or presence of 20 μM (±)-α-tocopherol. 
Treatment with 100 µM tert-butyl hydroperoxide (TBHP) was included as a positive control 
(Vessey et al., 1992). After removal of the exposure media and rinsing with HBSS, cells were 
collected by treatment with 0.25% trypsin/EDTA solution for 2 min, washed twice by 
centrifugation and resuspension in HBSS, and then re-suspended in HBSS. After 1-h incubation 
with 100 μM carboxy-H2DCF-DA in HBSS,  the fluorescence intensity of 200,000 cells in a 96-
well, black, clear-bottomed plate was measured using the Molecular Devices SpectraMax 
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Gemini M2e plate reader at an excitation wavelength of 492 nm and emission wavelength of 522 
nm. 
Cyclooxygenase activity assay. HTR-8/SVneo cells were seeded at a density of 5 × 10
4
 cells per 
well in a 24-well plate and cultured for 24 h at 37 °C. Cells were washed once with OptiMem1 
medium containing 1% FBS and 1% P/S, and then exposed to 20 μM BDE-47 in the absence and 
presence of 10 μM indomethacin, a non-selective COX inhibitor,  or 5 μM NS398, a COX-2 
specific inhibitor. After 24-h incubation, the culture medium was removed and cells were 
washed once with HBSS. Then, cells were incubated with 2.5 μM arachidonic acid in HBSS for 
4 h at 37 °C. After the 4-h incubation, the concentration of PGE2 was measured by sandwich 
ELISA following the manufacturer’s protocols. To determine ROS-related activation of 
prostaglandin pathways by BDE-47, HTR-8/SVneo cells were co-treated with 20 µM (±)-α-
tocopherol, a peroxyl radical scavenger for 24 h. Concentrations of PGE2 in the medium were 
analyzed by ELISA as described above. Release of PGE2 was expressed as pg/ml.  
RNA extraction and quantitative real-time polymerase chain reaction. After a 24-h incubation 
with BDE-47, cell lysates were collected and homogenized using QIA shredder. Total RNA was 
extracted from homogenized lysates using a RNeasy mini plus kit, and cDNA was synthesized 
from 1 μg of total RNA using a RT2 First Strand Kit. The procedures were performed according 
to instructions of the manufacturer. Quantitative real-time polymerase chain reaction (qPCR) was 
performed in a total volume of 25 μL containing 4 μL of cDNA template, 1 μL of a gene-specific 
primer (PTGS2, PTGES, HPGD), 12.5 μL of  RT2 SYBR Green qPCR Master Mix, and 7.5 μL 
of nuclease-free H2O using  CFX96 Real-Time PCR Detection System (Bio-Rad Laboratories, 
Hercules, CA, USA). A housekeeping gene, β-microglobulin, was co-amplified as an internal 
control. qRT-PCR was performed with an initial denaturation step of 10 min at 95°C, followed 
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by 40 cycles of 15 s at 95°C, 5 s at 60°C. At the end of each cycle, the fluorescence emitted by 
the SYBR Green was measured. After completion of the cycling process, samples were subjected 
to a temperature ramp (from 65°C to 95°C at 0.5°C/s) with continuous fluorescence monitoring 
for melting curve analysis. Signal intensities of target genes were quantified and normalized to 
the signal of β-microglobulin using Bio-Rad CFX manager software. The level of mRNA 
expression was presented as fold change compared to solvent controls. 
Western blot The HTR-8/SVneo cells were seeded at a density of 2.4 × 10
5 
cells per well in a 6-
well plate and cultured for 24 h at 37 °C. Cells were washed once with Optimem1 medium 
containing 1% FBS and 1% P/S, and then exposed to 20 μM BDE-47 in the absence or presence 
of 20 µM (±)-α-tocopherol. After a 24-h incubation, the culture medium was removed, and cells 
were washed twice with ice-cold dPBS, incubated with lysis buffer (0.5% IGEPAL, 250 mM 
NaCl, 50 mM tris-HCl, with a protease inhibitor tablets), and then scraped from the plates to 
collect cell lysates. After centrifugation of lysates, the supernatant was collected and stored at -
80°C until analysis. Total protein was quantified by BCA assay. The protein samples were boiled 
in sample buffer, and then 75 μg protein was subjected to SDS-polyacrylamide gel 
electrophoresis followed by electrotransfer to a PVDF membrane. Transfer efficiency was 
confirmed by reversible membrane staining (Memcode or Ponceau). Membranes were blocked at 
room temperature for 1 h with 5% milk in Tris-buffered saline supplemented with 0.1% tween 
(TBST; 20 mM Tris-HCl, 137 mM NaCl, pH 7.6). Membranes were probed with primary 
antibodies overnight at 4°C with agitation in 5% BSA TBST. Following washing with TBST 
under agitation for 3 min three times, membranes were incubated with alkaline phosphatase-
conjugated secondary antibodies for 1 h at RT in 5% milk TBST. All antibodies were diluted at 
1:2000. Bands were imaged after developing the blot with ECF for 5 min, and imaged on a 
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Fujifilm Fluorescent Image Analyzer FLA-5000. Images shown are representative of 3 
individual experiments. Densitometry was used to semi-quantitate data using Multi Gauge 
software (Fujifilm).  
Statistical analysis. Statistical analysis was performed with Sigma Plot 11.0 software (Systat 
Software Inc., San Jose, CA, USA). Data were analyzed either by one-way analysis of variance 
(ANOVA) or repeated measured two-way ANOVA. If significant effects were detected, the 
ANOVA was followed by Tukey post-hoc comparison of means. A P <0.05 was considered 
statistically different. Data were expressed as means ± SEM. All experiments were repeated at 
least three times and all treatments were performed at least in triplicate in each experiment. 
  
 
Results 
Effects of (±)-α-tocopherol on BDE-47-stimulated ROS production 
The DCF fluorescence assay was used to assess the effect of (±)-α-tocopherol on BDE-47-
stimulated ROS production. Treatment with 20 µM BDE-47 increased DCF fluorescence by 66% 
in the HTR-8/SVneo cells indicating increased generation of reactive species, and this BDE-
stimulated response was blocked by (±)-α-tocopherol cotreatment (P<0.05, Table 1.). Treatment 
with 100 µM TBHP, included as a positive control, increased DCF fluorescence by 176%. There 
were no statistically significant differences between non-treated controls, solvent controls, and 
(±)-α-tocopherol-treated groups, nor was the DCF fluorescence observed with 15 µM BDE-47 
statistically different from solvent controls.  
Effects of BDE-47 on PGE2 release 
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COX activity in HTR-8/SVneo cells was determined by measuring PGE2 release into culture 
medium from cells supplemented with exogenous arachidonic acid for 4 h. Treatment with 20 
µM BDE-47 induced a significant 1.8 fold-increase in PGE2 release from HTR-8/SVneo cells 
compared to the solvent control (P<0.05, Figure 3.1A).  Co-treatment with indomethacin, a 
nonspecific COX inhibitor, or NS-398, a COX-2 specific inhibitor, resulted in the complete 
suppression of BDE-47-stimulated PGE2 release to the levels comparable of the solvent control 
(P<0.05, Figure 3.1B), indicating that BDE-47-induced PGE2 release was dependent on COX 
activity. Notably, NS-398-mediated PGE2 decrease was similar to indomethacin-mediated PGE2 
decrease, suggesting that BDE-47-stimulated PGE2 production is mainly dependent on COX-2 
activity. There were no statistically significant differences between non-treated controls and 
solvent controls, nor did treatment with COX inhibitors alone significantly alter PGE2 release. 
Effects of BDE-47 on mRNA expression of PTGS2, PTGES and HPGD 
Expression of enzymes involved in prostaglandin synthesis and catabolism was measured at the 
mRNA levels. Treatment with 20 µM BDE-47 significantly increased mRNA expression of 
PTGS2 in HTR-8/SVneo cells compared to the solvent control at 4, 12 and 24 h by 5.3-fold, 4.5-
fold, and 4.7-fold, respectively (P<0.05, Figure 3.2A), in agreement with BDE-47-stimulated 
COX activity shown in Figure 3.1A. On the other hand, mRNA expression of PTGES, the gene 
for membrane-bound PGES-1 (mPGES-1), was suppressed 66% with 20 µM BDE-47 treatment 
compared with solvent control (P<0.05, Figure 3.2B). The mRNA expression of HPGD, the gene 
for 15-hydroxyprostaglandin dehydrogenase, was also reduced by 66% and 44% with 15 and 20 
µM BDE-47, respectively (P<0.05, Figure 3.2C). There were no statistically significant 
differences between non-treated controls and solvent controls at any time point, nor was the 
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mRNA expression observed with 5 and 10 µM BDE-47 statistically different from solvent 
controls. 
Effects of (±)-α-tocopherol treatment on BDE-47-stimulated PGE2 release 
To investigate the role of reactive oxygen species in BDE-47-induced PGE2 production, HTR-
8/SVneo cells were co-treated with 20 µM (±)-α-tocopherol for 24 h. As shown in Fig. 3.3, (±)-
α-tocopherol cotreatment inhibited COX activity stimulated by 20 µM BDE-47 in HTR-8/SVneo 
cells, reducing PGE2 concentrations in culture medium 22.5% compared to cultures exposed to 
BDE-47 without (±)-α-tocopherol pretreatment (Figure 3.3; P<0.05). There were no statistically 
significant differences between non-treated controls and solvent controls, nor did treatment with 
(±)-α-tocopherol alone significantly alter PGE2 release. 
Effects of (±)-α-tocopherol treatment on COX-2 and PGES expression 
To test whether suppression of BDE-47-induced COX activity by (±)-α-tocopherol cotreatment 
stems from changes in expression of COX-2 and PGES, qRT-PCR or western blot were 
conducted. Treatment with 20 µM BDE-47 induced a significant 3.2-fold increase in PTGS2 
mRNA expression in HTR-8/SVneo cells compared with solvent control (P<0.05, Figure 3.4). 
The mRNA expression of PTGS2 was not significantly changed with (±)-α-tocopherol 
cotreatment compared to non-(±)-α-tocopherol-treated groups (Figure 3.4), suggesting that ROS 
do not regulate COX-2 expression at the transcription level. Treatment with 20 µM BDE-47 
increased COX-2 protein expression by 2.0-fold compared with control (dashed line, Solvent 
Control with no (±)-α-tocopherol cotreatment) (P<0.05, Figure 3.5B). Cotreatment with (±)-α-
tocopherol did not significantly change BDE-47-stimulated COX-2 expression compared to non-
(±)-α-tocopherol-treated groups, implicating that ROS do not regulate COX-2 expression at the 
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translational level, either (Figure 3.5B). Protein expression of PGES was not significantly 
changed either with BDE-47 treatment or with (±)-α-tocopherol cotreatment (Figure 3.6).  
Discussion 
PGE2 is a pro-inflammatory mediator of critical trophoblast functions during placentation 
(Biondi, et al., 2006;  Horita, et al., 2007b;  Nicola, et al., 2005a;  Zhou, et al., 1997). The 
present study demonstrated that BDE-47, a prevalent flame retardant chemical in the 
environment and in human tissue samples, stimulated COX activity leading to increased PGE2 
release from a human first trimester EVT cell line, HTR-8/SVneo. In addition, we showed that 
treatment with BDE-47 resulted in differential expression of genes relevant to PGE2 pathways 
such as PTGS2, PGTES, and HPGD. Furthermore, we showed that BDE-47-stimulated COX-2 
activity was dependent on ROS formation in HTR-8/SVneo cells. The interaction of PBDEs and 
prostaglandin pathways in gestational tissues has not been extensively explored previously. 
Indeed, we found only one related previous study, which  showed that pre-exposure of placental 
explants to a PBDE mixture of congers 47, 99 and 100 enhanced placental pro-inflammatory 
response to heat-killed E. Coli, with increased PGE2 release and COX-2 expression (Peltier, et 
al., 2012).  
PGE2 production is mainly regulated by substrate availability (arachidonic acid) and the 
activity of COX, the rate limiting step in PGE2 production (Beharka et al., 2002;  Shanmugam et 
al., 2006). Because each treatment group was supplemented with exogenous arachidonic acid in 
the present study, stimulated PGE2 production is not affected by substrate availability but may 
be a reflection of increased COX activity (Hayek et al., 1994;  Hayek et al., 1997). Suppression 
of PGE2 release by co-treatment with COX inhibitors confirmed that BDE47-induced PGE2 
production was dependent on COX activity. Because treatment with NS-398, a COX-2-specific 
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inhibitor, was sufficient to completely suppress BDE47-stimulated PGE2 release, it is suggested 
that BDE47-mediated PGE2 production was mainly dependent on COX-2 activity in HTR-
8/SVneo cells.  
Stimulated PGE2 release could result from changes in the rate of protein synthesis or the 
rate of mRNA transcription (Beharka, et al., 2002). Our results showed that mRNA expression of 
PTGS2 was highly induced by BDE-47 treatment in HTR-8/SVneo cells whereas mRNA 
expression of PTGES and HPGD was reduced. Stimulated PTGS2 expression is consistent with 
increased COX activity we observed, supporting the hypothesis that increased gene transcription 
may contribute to the increased COX activity. Decreased HPGD expression may also contribute 
to the increased PGE2 concentrations in medium, due to reduced conversion of PGE2 to inactive 
metabolites (Tai, et al., 2006). Because PGES plays a role in the final step of PGE2 synthesis by 
converting PGH2 to PGE2, decreased PTGES mRNA expression is inconsistent with our 
findings of elevated PGE2 concentrations. However, western blot analysis on PGES protein 
showed that PGES protein abundance was not affected by BDE-47 treatment, suggesting that 
PGES protein remains at a level with sufficient activity for PGE2 production even in the 
circumstance of decreased PGES mRNA. An alternative explanation may involve isoforms of 
PGES, because there are three different PGESs including cytosolic PGES (cPGES) and two 
membrane-bound PGES (mPGES-1 and mPGES-2) (Samuelsson et al., 2007). Of these isoforms, 
cPGES and mPGES-2 are constitutively expressed, whereas mPGES-1 (PTGES) is mainly an 
induced isoform (Samuelsson, et al., 2007). Although the present study only measured mRNA 
expression of inducible mPGES-1 (PTGES), constitutively expressed cPGES and mPGES-2 
would convert PGH2 produced by COX to PGE2. Moreover, the rate of PGE2 synthesis is 
mainly dependent on COX activity (Beharka, et al., 2002;  Shanmugam, et al., 2006).  
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The present study provides new information that ROS play a role in activation of BDE-
47-mediated prostaglandin pathways in HTR-8/SVneo cells. Our finding that cotreatment with 
the antioxidant (±)-α-tocopherol suppressed BDE-47-stimulated ROS production and PGE2 
release suggests that ROS likely play a key role in BDE-47 stimulation of PGE2 release from 
HTR-8/SVneo cells.  Our results are in agreement with previous findings that α-tocopherol 
diminished ROS-stimulated placental PGF2α and thromboxane B2 (TXB2), as well as 
lipoperoxide levels (White et al., 2002). Interestingly, (±)-α-tocopherol cotreatment led to 
reduced COX activity without changing its expression, implicating post-translational regulation 
of COX activity by (±)-α-tocopherol. Similarly, α-tocopherol inhibited PGE2 production and 
COX activity, but had no effect on the expression of COX in murine macrophages and in Caco2 
cells (Jiang et al., 2000;  O'Leary et al., 2004;  Wu et al., 1998).  
Vitamin E (tocopherols and tocotrienols) is an effective biological antioxidant and lipid 
peroxide chain-breaking free radical scavenger (Wu, et al., 1998). It is reported that COX 
activity requires the presence of oxidant hydroperoxides (Hemler and Lands, 1980;  Kulmacz 
and Wang, 1995;  Smith et al., 1992).Therefore, it has been proposed that vitamin E may 
attenuate COX activity by scavenging the oxidant hydroperoxides necessary for COX activation 
(Wu et al., 2001). Increased lipid peroxidation by BDE-47 treatment in vitro is consistent with 
this mechanism (He et al., 2008;  Shao et al., 2008); however, we did not measure lipid 
peroxidation in the present study. Another proposed mechanism involves nitric oxide (NO) and 
peroxynitrite (ONOO) in regulation of COX activity (Wu, et al., 2001). Specifically, NO and 
ONOO stimulate COX activity without affecting COX expression (Salvemini et al., 1995;  Wu, 
et al., 2001),  and vitamin E reduces COX activity in murine macrophages by decreasing NO and 
ONOO production(Wu, et al., 2001). Production of NO, ONOO, and NO synthase activity were 
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reported in human first trimester primary trophoblasts, first trimester trophoblast cell lines, term 
primary trophoblasts, and term placenta (Al-Hijji et al., 2003;  Asagiri et al., 2003;  Dash et al., 
2003). Because NO can combine with superoxide to form ONOO (Wu, et al., 2001), our 
previous report of increased superoxide production by BDE-47 in HTR-8/SVneo cells (Park, et 
al., 2014) is consistent with the potential production of  ONOO in BDE-47-treated HTR-
8/SVneo cells. However, further study will be need to measure NO and ONOO levels in HTR-
8/SVneo cells stimulated by BDE-47 to test the roles of NO and ONOO on COX activity in 
human trophoblasts.  
Sakamoto et al. suggested an alternative explanation to post-translational modulation of 
COX activity by vitamin E (Sakamoto et al., 1993). They reported that PGE2 production 
stimulated by phorbol 12-myristate 13-acetate or A-23187 was inhibited by intraperitoneal 
injection of vitamin E via suppression of PLA2 activity and the subsequent decrease in 
arachidonic acid release (Sakamoto et al., 1991;  Sakamoto, et al., 1993). The latter mechanism 
may be relevant to our findings because we observed augmented PGE2 production with 
endogenous arachidonic acid in BDE-47-treated HTR-8/SVneo cells compared to controls 
without exogenous arachidonic acid supplementation (data not shown). However, we used an 
experimental approach that supplemented the cell culture medium with exogenous arachidonic 
acid because the observed PGE2 levels were close to the limit of detection in the assay 
otherwise. Therefore, the effect of vitamin E on PLA2 activity and subsequent arachidonic acid 
release was not tested in the present study because arachidonic acid was not limited in our 
experimental setting. Because prostaglandin production involves multiple step-wise reactions, 
we suggest that multiple mechanisms, not a single mechanism, may contribute to modulation of 
COX activity mediated by vitamin E. Besides, (±)-α-tocopherol treatment was not able to 
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suppress BDE-47-stimulated COX activity completely, supporting additional mechanisms. 
Therefore, further study will be needed to better understand the mechanisms for modulatory 
effects by vitamin E on COX activity. 
Our findings implicate PGE2 as a potential mediator of adverse impacts on trophoblast 
cellular function by PBDE exposure. A few studies indicate that PGE2 regulates trophoblast 
cellular functions in vitro. For example, PGE2 promoted migration of HTR-8/SVneo cells 
(Horita, et al., 2007b;  Nicola, et al., 2005a) and the stimulated migration was suppressed by 
COX-2 inhibition. In contrast, Biondi et al. (2006) showed that PGE2 suppressed the 
proliferation and migration of HTR-8/SVneo cells. These contradictory results may be due to 
different experimental conditions (media, serum concentration, exposure duration, cell density, 
etc.) generating divergent responses to the same stimuli. Regardless of these inconsistencies, 
these data implicate that PGE2 may play a role in regulating trophoblast cellular function and 
that dysregulation of PGE2 production at the gestational compartment may affect trophoblast 
invasion and migration that are critical for proper placentation (Pijnenborg, et al., 1983;  
Pijnenborg, et al., 1980). Moreover, dysregulation of PGE2 production within the gestational 
compartment has been linked to adverse birth outcomes such as intrauterine growth restriction, 
preeclampsia and preterm birth (Germain, et al., 1999;  Ness and Sibai, 2006). Because improper 
placentation has been associated with adverse obstetrical complications (Brosens, 1977;  Hustin, 
et al., 1983;  Kim, et al., 2003), further investigation will be needed to ascertain the potential 
relevance of BDE-47 stimulation of PGE2 on trophoblast invasion and placental function. 
In conclusion, this is the first study to show that treatment with BDE-47, a predominant flame 
retardant chemical found in human tissues, stimulated COX activity and expression of COX2, 
leading to increased conversion of arachidonic acid to PGE2 in human first trimester placental 
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cells. In addition, (±)-α-tocopherol cotreatment reduced BDE-47-stimulated COX activity 
without affecting mRNA and protein expression of COX2, implicating post-translational 
regulation of COX activity. Because dysregulation of PGE2 has been implicated in improper 
trophoblast invasion and placental dysfunction, and associated with adverse birth outcomes, 
further investigation of the impact of BDE-47 on trophoblast function is warranted. 
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Table 3.1. Quantification of reactive oxygen species production in HTR-8/SVneo cells
a 
 
Treatment DCF fluorescence intensity 
NT 177.88 ±  5.22 
Solvent control 178.79 ±  7.38 
15 µM BDE-47  236.63 ± 16.60 
20 µM BDE-47   296.81 ± 18.70* 
20 µM BDE-47+ 20 µM (±)-α-tocopherol 183.88 ±  7.96 
100 µM TBHP   493.82 ± 40.47* 
20 µM (±)-α-tocopherol  181.39 ±  6.97# 
 
 a
 HTR-8 cells were non-treated (NT; control), or were treated with DMSO (solvent control), 
BDE-47 or tert-butyl hydroperoxide (TBHP, positive control) in the absence or presence of (±)-
α-tocopherol for 4 h. After 1-h incubation with 100 µM carboxy-H2DCF-DA, the fluorescence 
intensity was measured using a spectrophotometry. Values represent the means ± SE of 3 
independent experiments containing 3 replicates each. *P<0.05, significant compared to solvent 
control. 
#
P<0.05, significantly different compared to 20 µM BDE-47-treated group. 
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Figure 3.1. BDE-47 effects on COX activity in HTR-8/SVneo cells.   
HTR-8/SVneo cells were non-treated (NT, control), or treated with solvent control (DMSO, 0.7% 
v/v) or BDE-47 for 24 h in the absence or presence of the nonspecific cyclooxygenase (COX) 
inhibitor indomethacin or the COX-2 specific inhibitor NS 398. COX activity was inferred by 
quantification of PGE2 in the culture medium from cells stimulated with exogenous arachidonic 
acid after BDE-47 treatment. A) BDE-47 effects on COX activity in HTR-8/SVneo cells. B) 
Suppression of BDE47-stimulated PGE2 release by treatment with COX inhibitors. Bars 
represent the means of 3 independent experiments containing 3 replicates each ±SE. *P<0.05, 
significant compared to solvent control. #P<0.05, significantly different from each other. 
*P<0.05, significant compared to solvent control. 
#
P<0.05, significantly different from each 
other. 
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Figure 3.2. BDE-47 effects on mRNA expression of PTGS-2, PTGES, and HPGD.  
HTR-8/SVneo cells received no treatment (non-treated control, NT), or were treated with solvent 
control (DMSO, 0.7% v/v) or BDE-47 for 4, 12, or 24 h, and then mRNA expression of target 
genes was quantified by qRT-PCR. A) Time-course of BDE-47 concentration-dependent effects 
on PTGS2 mRNA expression. B) BDE-47 concentration-dependent effects on PTGES mRNA 
expression. C) BDE-47 concentration-dependent effects on HPGD mRNA expression. Bars 
represent the means of 3 independent experiments containing 3 replicates each ±SE. *P<0.05, 
significant compared to solvent control within each time point. 
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Figure 3.3. (±)-α-Tocopherol effects on BDE-47-stimulated PGE2 release.  
HTR-8/SVneo cells received no treatment (non-treated control, NT), or were treated with solvent 
control (DMSO, 0.7% v/v) or BDE-47 for 24 h in the absence or presence of (±)-α-tocopherol. 
COX activity was inferred by quantification of PGE2 in the culture medium of cells stimulated 
with exogenous arachidonic acid after BDE-47 treatment. Bars represent the means of 3 
independent experiments containing 3 replicates each ±SE. *P<0.05, significant compared to 
solvent control. #P<0.05, significantly different from each other. 
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Figure 3.4. (±)-α-Tocopherol effects on BDE-47-stimulated PTGS2 mRNA expression.  
HTR-8/SVneo cells received no treatment (non-treated control, NT), or were treated with solvent 
control (DMSO, 0.7% v/v) or BDE-47 for 24 h in the absence or presence of (±)-α-tocopherol. 
The mRNA expression of PTGS2 was quantified by qRT-PCR. Bars represent the means of 3 
independent experiments containing 3 replicates each ±SE. *P<0.05, significant compared to 
solvent controls. 
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Figure 3.5. (±)-α-Tocopherol effects on BDE-47-stimulated COX-2 protein expression.  
HTR-8/SVneo cells received no treatment (non-treated control, NT), or were treated with solvent 
control (DMSO, 0.7% v/v) or BDE-47 for 24 h in the absence or presence of (±)-α-tocopherol. A) 
Representative image of western blotting for COX-2 and β-tubulin loading control. 1: NT, 2: 
Solvent control, 3: 20 µM BDE-47, 4: NT+20 µM (±)-α-tocopherol, 5: Solvent control +20 µM 
(±)-α-tocopherol, 6: 20 µM BDE-47+20 µM (±)-α-tocopherol . B) Fold changes in COX-2 
protein expression relative to control (dashed line, Solvent control with no (±)-α-tocopherol 
cotreatment). Densitometry data for COX-2 were normalized to the β-tubulin loading control. 
Data represent mean ± SEM for 3 experiments.*P<0.05, significant compared to control.  
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Figure 3.6. (±)-α-Tocopherol effects on PGES protein expression. 
HTR-8/SVneo cells received no treatment (non-treated control, NT), or were treated with solvent 
control (DMSO, 0.7% v/v) or BDE-47 for 24 h in the absence or presence of (±)-α-tocopherol. A) 
Representative image of western blotting for PGES and β-tubulin loading control. 1: NT, 2: 
Solvent control, 3: 20 µM BDE-47, 4: NT+20 µM (±)-α-tocopherol, 5: Solvent control +20 µM 
(±)-α-tocopherol, 6: 20 µM BDE-47+20 µM (±)-α-tocopherol . B) Fold changes in PGES protein 
expression relative to control (dashed line, Solvent control with no (±)-α-tocopherol cotreatment). 
Densitometry data for PGES were normalized to the β-tubulin loading control. Data represent 
mean ± SEM for 3 experiments.*P<0.05, significant compared to control.  
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 PROTECTIVE EFFECT OF NUCLEAR FACTOR E2-CHAPTER 4.
RELATED FACTOR 2-DEPENDENT ANTIOXIDANT RESPONSE 
ELEMENT ACTIVATION ON INFLAMMATORY RESPONSE IN 
HUMAN FIRST TRIMESTER EXTRAVILLOUS TROPHOBLASTS 
EXPOSED TO BROMINATED DIPHENYL ETHER-47 
 
Abstract 
Polybrominated diphenyl ethers (PBDEs) are widely used flame retardant compounds. 
Brominated diphenyl ether (BDE)-47 is one of the most prevalent PBDE congeners found in 
human breast milk, serum and placenta. Exposure to BDE-47 has been linked to adverse 
pregnancy outcomes in humans including preterm birth, low birth weight and stillbirth. Although 
the underlying mechanisms of adverse birth outcomes are poorly understood, critical roles for 
oxidative stress and inflammation are implicated. The present study investgated the role of 
nuclear factor E2-related factor 2 (Nrf2), a redox-sensitive transcription factor, in oxidative stress 
responses in a human extravillous trophoblast cell line, HTR-8/SVneo cells, and examined the 
protective roles of Nrf2 on BDE-47-induced inflammatory re sponses in the cells.  After 6 or 24 
h exposure of HTR-8 cells to BDE-47, intracellular glutathione (GSH) concentration, Nrf2 
transactivation, and expression of 84 redox-regulated genes were assayed. Treatment of HTR-8 
cells with 20 μM BDE-47 for 24 h resulted in differential expression of redox-sensitive genes 
compared to solvent control, as assayed with a commercial Oxidative Stress PCR Array. 
Treatment of HTR-8 cells with 5, 10, 15, and 20 μM BDE-47 for 24 h increased intracellular 
GSH levels compared to solvent control, consistent with increased mRNA expression of genes 
related to GSH synthesis. At 24 h, 20 μM BDE-47 induced significant increases in the Nrf2 
activity. To test the protective role of Nrf2 activation on BDE-47-stimulated inflammation, HTR-
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8/SVneo cells were pretreated with tert-butyl hydroquinone (tBHQ) or sulforaphane,known Nrf2 
inducers which induced cellular antioxidant defenses of the HTR-8/SVneo cells, and then treated 
with BDE-47. Pretreatment with tBHQ or sulforaphane reduced BDE-47 stimulated pro-
inflammatory IL-6 release, suggesting that Nrf2 may play a protective role against BDE-47-
mediated inflammatory responses in HTR-8/SVneo cells. These results suggest that Nrf2 
activation significantly attenuated BDE-47-induced inflammation by augmentation of cellular 
antioxidative system via upregulation of Nrf2 signaling pathways, and that Nrf2 induction may 
be a potential therapeutic target to reduce adverse pregnancy outcomes associated with toxicant-
induced oxidative stress and inflammation. Further investigation about the mechanisms of the 
anti-inflammatory effect mediated by Nrf2 induction is warranted. 
 
Introduction 
Polybrominated diphenyl ethers (PBDEs) are synthetic flame-retardants widely used in 
polyurethane foam, textiles, plastics, building materials and insulation (Hites, 2004). BDE-47 
(2,2′,4,4′-tetra-BDE) is one of the most prevalent congers found in human tissues and 
environmental samples (Hites, 2004), detected in nearly all human serum samples from the 
NHANES 2003-2004 biomonitoring assessment (Sjodin et al., 2008). Because of PBDEs’ 
environmental persistence and toxicity, the US EPA has identified PBDEs as a priority human 
health concern (U.S. Environmental Protection Agency, 2006).  Limited studies report  
associations between PBDE exposure and adverse birth outcomes such as preterm birth, low 
birth weight or stillbirth (Breslin et al., 1989;  Wu et al., 2010). Although PBDEs have been 
found in gestational tissues such as human placenta (Frederiksen et al., 2009), extraplacental 
membranes (Miller et al., 2009), amniotic fluid (Miller et al., 2012), and umbilical cord blood 
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(Frederiksen, et al., 2009), studies of mechanisms by which PBDEs act on gestational tissues 
during pregnancy are limited. 
Improper regulation of the inflammatory networks has been associated with adverse 
pregnancy outcomes such as miscarriage, preeclampsia (PE), intrauterine growth restriction 
(IUGR), and preterm labor (Orsi and Tribe, 2008;  Tjoa et al., 2004). Specifically, increased 
levels of inflammatory mediators such as interleukin (IL)-6 and C-reactive protein are associated 
with the pathophysiology of PE and IUGR  (Tjoa et al., 2003;  Vince et al., 1995), and women 
who delivered preterm had higher rates of placental ischemia and abnormal placentation than 
women who delivered at term (Germain et al., 1999;  Kim et al., 2003). Moreover, increased 
levels of IL-8 and IL-6 in cervical fluid, amniotic fluid and maternal serum have beeb associated 
with preterm birth (Goldenberg et al., 2005). It is suggested that cytokine dysregulation alters 
extravillous trophoblast (EVT) functions during placentation, leading to placental alterations that 
may compromise pregnancy (Anton et al., 2012). 
A few studies reported modulation of innate immune responses by BDE-47 treatment in 
peripheral blood mononuclear cells or placental explants (Ashwood et al., 2009;  Peltier et al., 
2012). Our previous study showed that BDE-47 treatment of a human first trimester EVT cell 
line, HTR-8/SVneo, stimulated mRNA and protein expression of the pro-inflammatory cytokines 
IL-6 and IL-8 (Park et al., 2014). Furthermore, suppression of BDE-47-induced IL-6 production 
by antioxidant treatments implicates a role for reactive oxygen species (ROS) in the initiation 
and regulation of BDE-47-stimulated inflammatory responses in the cells (Park, et al., 2014). 
Similarly, the antioxidant N-acetylcysteine (NAC) prevents LPS-stimulated parturition, fetal 
death in mice and LPS-induced release of pro-inflammatory cytokines from human 
extraplacental membranes in vitro (Buhimschi et al., 2003b;  Cindrova-Davies et al., 2007). 
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Together, these findings suggest an interaction between oxidative stress and inflammatory 
pathways in gestational compartments. In fact, a growing body of literature shows that ROS can 
function as signaling molecules in mammalian cells (Finkel, 1998;  Khan and Wilson, 1995;  
Remacle et al., 1995) to regulate expression of genes for inflammatory cytokines, chemokines, 
and anti-inflammatory molecules (Reuter et al., 2010).  
Nuclear factor E2-related factor 2 (Nrf2) is the master transcriptional regulator of 
oxidative and xenobiotic stress responses (Tjoa, et al., 2003). In response to oxidative insults, 
Nrf2 binds to the antioxidant response element (ARE) in a promoter and activates ARE-
regulated genes. A wide range of natural and synthetic small molecules such as tert-butyl 
hydroquinone (tBHQ) and sulforaphane induce Nrf2 activity to exert cytoprotective activities 
(Gharavi et al., 2007;  Juge et al., 2007). Especially, the anti-inflammatory effect of Nrf2 
activation have been implicated in a variety of experimental models (Khor et al., 2006;  
Rangasamy et al., 2004;  Rangasamy et al., 2005;  Thimmulappa et al., 2006). Although the 
mechanisms for the anti-inflammatory effects of Nrf2 are not fully understood, it is suggested 
that augmentation of cellular antioxidant responses via up-regulation Nrf2 signaling pathway and 
inhibition of NF-κB signaling pathway may have roles in these responses (Jin et al., 2011;  
Khodagholi and Tusi, 2011). 
Despite its importance, there are few studies about the roles of Nrf2 in gestational tissues during 
pregnancy. It has been recently reported that dysregulation of Nrf2 signaling pathways is 
associated with adverse birth outcomes such as PE and IUGR outcomes (Chigusa et al., 2012;  
Kweider et al., 2012;  Loset et al., 2011;  Wruck et al., 2009). To our knowledge, however, there 
is no report about the role of Nrf2 activation in the regulation of toxicant-stimulated 
inflammatory responses in human first trimester placental cells. Because ROS have been 
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implicated in the activation of inflammatory responses in gestational compartments (Buhimschi 
et al., 2003a;  Cindrova-Davies, et al., 2007) and our previous study showed that BDE-47-
stimulated cytokine production was dependent on ROS formation (Park, et al., 2014), the present 
study aimed to investigate the protective roles of Nrf2 on BDE-47-induced inflammatory 
responses in the HTR-8/SVneo cell model. 
Materials and Methods 
Chemicals and assay kits. BDE-47 was purchased from AccuStardard (New Haven, CT, USA). 
dimethyl sulfoxide (DMSO), tBHQ, and sulforaphane purchased from Sigma Aldrich (St. Louis, 
MO, USA). RPMI medium 1640, fetal bovine serum (FBS), OptiMem 1 reduced-serum medium, 
10 mM non-essential amino acids in minimal essential medium, 0.25% trypsin/EDTA solution 
and penicillin/streptomycin were purchased from Invitrogen Life Technologies (Carlsbad, CA, 
USA). Sandwich enzyme-linked immunosorbent assay (ELISA) kit for human IL-6 was 
purchased from R & D systems (Minneapolis, MN, USA). Antioxidant Response Cignal reporter 
assay kit, NF-κB Cignal reporter assay kit, Attractene transfection reagent, QIAshredder 
columns, and RNeasy kits were purchased from Qiagen (Germantown, MD). Dual Luciferase, 
GSH-Glo™ Glutathione Assays were purchased from Promega (Madison, WI). iScript cDNA 
synthesis kits and SsoAdvanced SYBR Green Supermix were purchased from Bio-Rad 
(Hercules, CA). Primers were synthesized by Integrated DNA Technologies (Coralville, IA).   
Cell Culture and treatment.  The human first trimester extravillous trophoblast cell line HTR-
8/SVneo was kindly provided by Dr. Charles S. Graham (Queen's University, Kingston, ON, 
Canada). Cells between passages 71 and 84 were cultured in RPMI 1640 medium supplemented 
with 10% FBS and 1% penicillin/streptomycin  at 37°C in a 5% CO2 humidified atmosphere. 
Cells were grown to a confluence of 70-90% before treatment. Cells were washed with OptiMem 
104 
 
1 containing 1% FBS and 1% penicillin/streptomycin twice and acclimated with the medium for 
1 h at 37 °C. From solutions of 5, 10, 15 and 20 mM BDE-47 in DMSO, exposure media 
containing 5, 10, 15 and 20 µM BDE-47 were made in OptiMem 1 containing 1% FBS and 1% 
P/S immediately prior to initiating the experiment. The final concentration of DMSO in medium 
was 0.7 % (v/v).  
Measurement of intracellular gluthathione concentration. Changes in intracellular glutathione 
(GSH) levels by BDE-47 treatment on HTR-8/SVneo cells were quantified using the GSH-Glo 
Glutathione assay kit (Promega). Cells were seeded at a density of 10,000/well in a white, clear-
bottomed 96-well plate and incubated for 24 h at 37°C. Then, cells were exposed to BDE-47 for 
0.5, 4 or 24 h at 37°C. To assay for GSH, the culture medium was removed and 100 µl of GSH-
Glo
TM
 Reagent was added to each well. After a 30 min-incubation, 100 µl of Luciferin Detection 
Reagent was added to each well, followed by a additional 15-min incubation. The plate was then 
read in a luminometer. To examine the effect of Nrf2 induction on GSH production, cells were 
pretreated with tBHQ for 1 h or sulforaphane for 24 h prior to BDE-47 treatment. After treatment 
with BDE-47, GSH levels were measured following the manufacturer’s protocol.  
Oxidative stress gene array and qRT validation. Changes in mRNA expression of 84 target 
genes by BDE-47 treatment on HTR-8 cells were quantified using the Oxidative Stress 
Responses PCR Array (SA biosciences; Valencia, CA). Cells were treated with DMSO (solvent 
control, 0.7% v/v) or BDE-47 (20 µM) for 4 or 24 h. After incubation, cell lysates were collected 
and homogenized using QIA shredder (Qiagen; Valencia, CA). Total RNA was extracted from 
homogenized lysates using RNeasy mini plus kit (Qiagen; Valencia, CA), and cDNA was 
synthesized from 1 μg of total RNA using iScript cDNA synthesis kits (Bio-Rad; Hercules, CA) 
following the manufacturer’s protocols. For the array, cDNA from the solvent control and BDE-
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47 treatment groups were analyzed using the Applied Biosystems 7900HT Sequence Detection 
System following the SABiosciences recommended protocol. Fold Changes were calculated 
from ΔCT values (gene of interest CT values – Average of all housekeeping gene CT values) 
using the ΔΔCT method. Mean ΔCT values were compared between groups using paired t-tests 
from the Limma package of Bioconductor (Smyth, 2004). With qRT-PCR, we validated the 
findings of the array for those genes with significant mRNA expression changes that were 
approximately two-fold or more with 20 µM BDE-47 treatment: Solute carrier family 7 (anionic 
amino acid transporter light chain, xc- system), member 11(SLC7A11), Heme oxygenase 
(decycling) 1(HMOX1), Aldehyde oxidase 1 (AOX1), Sulfiredoxin 1(SRXN1), Prostaglandin-
endoperoxide synthase 2 (PTGS2), Sequestosome 1 (SQSTM1), Prion protein (PRNP), 
Glutathione reductase (GSR), Ring finger protein 7 (RNF7), Thioredoxin reductase 1 (TXNRD1), 
Four and a half LIM domains 2 (FHL2), Glutamate-cysteine ligase , modifier subunit (GCLM), 
Glutathione peroxidase 1(GPX1), Ferritin, heavy polypeptide 1 (FTH1), and  24-
dehydrocholesterol reductase (DHCR24). The qRT-PCR reactions were prepared with 
SsoAdvanced SYBR Green Supermix and primers, and run on a Bio-Rad CFX96 Real time 
C1000 thermal cycler following the manufacturer’s recommended protocols. The mRNA levels 
of each gene of interest were normalized to β-2-micoglobulin mRNA levels and presented as fold 
change compared to solvent controls. 
Measurement of ARE reporter activity. Nuclear factor (erythroid-derived 2)-like 2 (Nrf2) 
activity was assessed using a commercially available reporter construct (SABiosciences, 
Qiagen). The reporter consists of a mixture of inducible firefly luciferase gene downstream of 
tandem antioxidant response element (ARE) consensus binding site repeats and constitutive 
Renilla luciferase gene controlled by cytomegalovirus (CMV) promoter. HTR-8/SVneo cells 
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were seeded at a density of 20,000/well  in white, clear bottom 96-well plates containing 
transfection reagent complexed with negative control, positive control, or ARE reporter 
constructs in Opti-MEM 1 supplemented with 1% NEAA and 3% FBS. After transfection for 6 h 
at 37°C, transfection complex was replaced with the fresh medium and cells were incubated for 
18 h at 37°C.  Cells were then pretreated with tBHQ for 1 h or with sulforaphane for 24 h prior 
to treatment with BDE-47 for 24 h. Treatment solutions were prepared in  OptiMEM 1 
supplemented with 1% NEAA, 1% FBS and 1% P/ S. After treatment with BDE-47, medium 
was aspirated, and cells were passively lysed. Dual luciferase assays were performed according 
to manufacturer’s instructions. Luminescence was measured using a GloMax Multi Plus 
detection system (Promega) with two injectors. ARE firefly luciferase activity was normalized to 
luciferase activity of Renilla, included as an internal control accounting for cell number and 
transfection efficiency. Data are presented as the fold change in luciferase activity normalized to 
the control.  
Measurement of NF-κB reporter activity. NF-κB activity was assessed using a commercially 
available reporter construct (SABiosciences, Qiagen). The reporter consists of a mixture of 
inducible firefly luciferase gene downstream of tandem NF-κB consensus binding site repeats 
and constitutive Renilla luciferase gene controlled by a CMV promoter. The assay was 
conducted as described above for ARE reporter activity. NF-κB firefly luciferase activity was 
normalized to luciferase activity of Renilla. Data are presented as the fold change in luciferase 
activity normalized to the control. 
Measurement of cytokine release. The HTR-8/SVneo cells were seeded at a density of 5 × 10
4
 
cells per well in a 24-well plate and cultured for 24 h at 37 °C. Cells were washed once with 
OptiMem1 medium containing 1 % FBS and 1% P/S and pretreated with tBHQ for 1 h or 
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sulforaphane for 24 h prior to 20 µM BDE-47 treatment for 24 h.  The concentration of  IL-6 in 
the medium was then analyzed by ELISA as described above, expressed as pg/ml.  
Statistical analysis. Statistical analysis was performed with Sigma Plot 11.0 software (Systat 
Software Inc., San Jose, CA, USA). Data were analyzed either by one-way analysis of variance 
(ANOVA) or repeated measured two-way ANOVA. If significant effects were detected, the 
ANOVA was followed by Tukey post-hoc comparison of means. A P <0.05 was considered 
statistically different. Data were expressed as means ± SEM. 
Results 
Effect of BDE-47 on cellular GSH  
Because our previous work showed that BDE-47 increases generation of reactive oxygen species 
(Park, et al., 2014), we quantified intracellular GSH concentration in HTR-8/SVneo cells after 
24-h treatment with BDE-47. Treatment with 5, 10, 15 and 20 µM BDE-47 increased GSH 
production by 22%, 39%, 29%, and 52%, respectively, compared to the solvent control (Figure 
4.1A; P<0.05).  Treatment with 20 µM BDE-47 resulted in significantly increased GSH 
production compared to treatment with 5 µM BDE-47, indicating a concentration-dependent 
response (Figure 4.1A; P<0.05). To examine the temporal changes in GSH production in BDE-
47-treated cells, GSH levels were measured at 0.5, 4, and 24 h after treatment with BDE-47. 
Treatment with 20 µM BDE-47 stimulated GSH production after 24 h (51% compared to solvent 
control), as observed in the prior experiment, but there were no statistically significant changes 
in GSH levels at 0.5 or 4 h (Figure 4.1B; P<0.05) (Figure 4.2B).  Treatment with 50 µM BSO, 
included as a positive control, significantly decreased GSH at 4 h and almost completely 
depleted GSH after 24 h. 
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Effect of BDE-47 treatment on ARE reporter activity 
To investigate possible explanation for the increased cellular GSH observed with BDE-47, we 
evaluated BDE-47-stimulated Nrf2 activation using an ARE reporter activity assay. After 24 h 
treatment, 10 and 20 µM BDE-47 increased ARE activity by 1.7fold and 2-fold, respectively, 
compared to solvent control, indicating Nrf2 activation (Figure 4.2; P<0.05). We did not observe 
statistically significant changes at 6 h, although slight increases in ARE activity were suggested.  
Oxidative stress PCR array 
Probing BDE-47 activation of antioxidant responses further, we used the Oxidative Stress PCR 
Array to investigate changes in expression of redox-sensitive genes. We identified 15 genes with 
mRNA expression significantly changed two-fold or more by 20 µM BDE-47 treatment 
compared to solvent  control (for complete mRNA array data, see Appendix, Table 1). Changes 
in expression of the array-identified genes were then examined by qRT-PCR. Consistent with the 
array results, treatment with 20 µM BDE-47 for 24 h significantly increased mRNA expression 
of HMOX1, PTGS2, and PRNP by 4.9-fold, 4.7-fold, and 2.5-fold, respectively, and nearly 
abolished mRNA expression of  DHCR24 to 0.08-fold relative to solvent control (Figure 4.3A, 
P<0.05). The mRNA expression of genes involved in GSH redox cycling was also induced by 20 
µM BDE-47 treatment,  with SLC7A11, SRXN1, GCLM, and GPX1 increased 3-fold, 1.8-fold, 
1.5-fold and 1.7-fold, respectively (Figure 4.3B, P<0.05). BDE-47 suppressed mRNA expression 
of GSR to 0.7-fold relative to solvent control (Figure 4.3B, P<0.05). We did not observe any 
significant changes in mRNA expression with 15 µM BDE-47. 
Effect of Nrf2 inducers on ARE reporter activity  
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We validated the efficacy of tBHQ and sulforaphane as Nrf2 inducers in the HTR-8/SVneo cells 
and investigated effects of the Nrf2 inducers on BDE-47-stimulated Nrf2 activation using an 
ARE reporter activity assay. Treatment with 20 and 50 µM tBHQ increased ARE activity by 1.7- 
fold and 2.4-fold, respectively, compared with controls not exposed to tBHQ (No BDE-47 with 0 
µM tBHQ , Fig. 4.4A; P<0.05). Similarly, 10 µM sulforaphane increased ARE activity by 1.8-
fold compared with controls not exposed to sulforaphane (No BDE-47 with 0 µM sulforaphane, 
Fig. 4.4B; P<0.05). No statistically significant changes were observed with 5 µM tBHQ, or with 
5 and 7.5 µM sulforaphane. These results identified 20 and 50 µM tBHQ, and 10 µM 
sulforaphane, as effective concentrations for Nrf2 activation. Because subsequent experiments 
would utilize co-treatments of BDE-47 with the Nrf2 inducers, we also measured ARE activity 
in the presence of BDE-47. µMPretreatment with 0, 5, 20, and 50 µM tBHQ followed by 20 µM  
BDE-47 treatment increased ARE activity 1.9-fold, 2.8-fold, 3-fold, and 3.5-fold, respectively, 
compared to control (No BDE-47 with 0 µM  tBHQ) (Figure 4.4A; P<0.05). Treatment with 50 
µM tBHQ increased ARE activity significantly higher than 0, 5 µM tBHQ and 10 µM tBHQ 
within the 20 µM BDE-47 treated group, showing a concentration-dependant reponse. BDE-47-
treated cells always showed significantly higher ARE activity compared to cells with no BDE-47 
and the same tBHQ concentration (Figure 4.4A; P<0.05). Similarly, pretreatment with 0, 5, 7.5, 
and 10 µM sulforaphane followed by 20 µM  BDE-47 treatment increased ARE activity 1.6-fold, 
1.8-fold, 2-fold, and 3-fold, respectively, in BDE-47-treated cells compared to control (No BDE-
47 with 20 µM  tBHQ) (Figure 4.4B; P<0.05). Treatment with 10 µM sulforaphane resulted in 
significantly increased activity compared to 5 and 7.5 µM sulforaphane, showing a 
concentration-dependent increase (Figure 4.4B; P<0.05). BDE-47-treated cells showed 
significantly higher ARE activity compared to cells with no BDE-47 and the same sulforaphane 
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concentration (Figure 4.4B; P<0.05). These data show that pretreatment with Nrf2 inducers 
stimulates Nrf2 transactivation, leading to increased antioxidant capacity in HTR-8/SVneo cells.  
Effect of Nrf2 inducers on BDE-47-stimulated GSH production 
To examine the effect of Nrf2 transactivation by tBHQ on cellular antioxidative capacity, 
changes in intracellular antioxidant GSH concentrations were assayed. In cells without BDE-47-
treatment, 20 and 50 µM tBHQ increased GSH production 20% and 37%, respectively, 
compared to control (No BDE-47 with 0 µM tBHQ) (Figure 4.5; P<0.05). In 20 µM BDE-47-
treated cells, pretreatment with 0, 10, 20 and 50 µM tBHQ increased GSH production by 17%, 
27%, 40%, and 63%, respectively, compared to control (No BDE-47 with 0 µM tBHQ) (Figure 
4.5; P<0.05). tBHQ induced GSH production in a concentration-dependent manner, such that 
pretreatment with 50 µM tBHQ significantly increased GSH compared with pretreatment with 
10 and 20 µM tBHQ in those cells subsequently exposed to 20 µM BDE-47 (Figure 4.5; P<0.05). 
BDE-47-treated cells showed significantly higher ARE activity compared to no BDE-47-treated 
cells (Figure 4.5; P<0.05). These findings suggeset that cells pretreated with tBHQ may have an 
augmented defensive capacity against BDE-47 treatment with increased GSH production.  
Effect of Nrf2 inducers on expression of HMOX1 and GCLM  
To test activation of Nrf2 pathways by Nrf2 inducers further, mRNA expression of the 
antioxidant genes HMOX1 and GCLM was quantified in HTR-8/SVneo cells after Nrf2 
induction by pretreatment with tBHQ followed by treatment with BDE-47. 20 µM BDE-47 
treatment resulted in significantly increased mRNA expression of HMOX1 and GCLM 
compared to control (No BDE-47 with 0 µM tBHQ at all tBHQ concentrations (0, 10, 20 and 50 
µM ) (Figure 4.6 A and B; P<0.05). Pretreatment with 50 µM tBHQ significantly increased 
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HMOX1 mRNA expression by 68% compared to no pretreatment in BDE-47-treated cells 
(Figure 4.6A; P<0.05). However, mRNA expression of GCLM was not statistically significantly 
increased (Figure 4.6B; P=0.062). We did not observe any significant changes in solvent controls 
(No BDE-47) with tBHQ pretreatment. Increased expression of antioxidant enzymes by tBHQ 
suggests that cells pretreated with tBHQ might be able to protect themselves from BDE-47-
stimulated oxidative damage.  
Effect of Nrf2 inducers on IL-6 production 
To investigate the roles of Nrf2 induction on the regulation of BDE-47-stimulated IL-6, HTR-
8/SVneo cells were pretreated with tBHQ or sulforaphane prior to exposure to BDE-47. 
Treatment with BDE-47 increased IL-6 release in HTR-8/SVneo cells compared to solvent 
controls (No BDE-47) regardless of tBHQ or sulforaphane pretreatment (Figures 4.7A and 
Figure 4.7B, respectively; P<0.05). Notably, pretreatment with 50 µM tBHQ significantly 
suppressed BDE-47-stimulated IL-6 release by 55% from HTR-8/SVneo cells compared to 20 
µM BDE-47 with 0 µM tBHQ (Figure 4.7A; P<0.05). Similarly, pretreatment with 10 µM 
sulforaphane decreased BDE-47-induced IL-6 release by 65 % (Figure 4.8B; P<0.05) compared 
to 20 µM BDE-47 with 0 µM sulforaphane. We did not observe any significant changes in 
solvent controls (No BDE-47) with tBHQ or sulforaphane pretreatment. 
Effect of tBHQ on NF-κB transactivation 
It is implicated that Nrf2 activation exhibits its anti-inflammatory effect partly via suppression of 
an inflammatory transcription factor NF-κB (Jin, et al., 2011). To examine the possible 
involvement of NF-κB in BDE-47 mediated IL-6 release and suppression of IL-6 release by Nrf2 
inducion, NF-κB reporter activity was measured. Treatment with 20 µM BDE-47 increased NF-
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κB reporter activity 3.4-fold compared to control (No BDE-47 with 0 µM tBHQ) (Figure 4.8; 
P<0.05). Pretreatment with tBHQ suppressed the BDE-47-stimulated activation of NF-κB by 32% 
(Figure 4.8; P<0.05). Treatment with tBHQ alone had no statistically significant effect compared 
with solvent controls not exposed to tBHQ (No BDE-47 treatment groups; Figure 4.8).  
Discussion 
PBDEs are flame retardant chemicals commonly detected in human serum, with BDE-47 
among the most abundant of the PBDE congeners detected (Sjodin, et al., 2008). During 
pregnancy, BDE-47 accumulates in human placenta (Frederiksen, et al., 2009;  Miller, et al., 
2009), extraplacental membranes (Miller, et al., 2009), and amniotic fluid (Miller, et al., 2012). 
Previously, we showed that BDE-47 directly stimulates proinflammatory cytokine responses in 
the first trimester human EVT cell line, HTR-8/SVneo (Park, et al., 2014). In the present study, 
we show that BDE-47 stimulated Nrf2-mediated oxidative stress responses in HTR-8/SVneo 
cells, resulting in differential expression of redox-sensitive genes, transactivation of Nrf2 and 
NF-κB, and augmentation of GSH. Especially, we report novel findings that induction of Nrf2 
activity by Nrf2 inducers suppressed BDE-47-stimulated proinflammatory IL-6 release and NF-
κB reporter activity in HTR-8/SVneo cells, implicating crosstalk between Nrf2 and NF-κB 
pathways.  
Consistent with ROS generation previously described (Park, et al., 2014), BDE-47 
treatment resulted in differential expression of the redox-sensitive genes HMOX1, PTGS2, 
PRNP, DHCR24, SLC7A11, SRXN1, GSR, GCLM, and GPX1 in HTR-8/SVneo cells. We 
observed stimulated mRNA expression of HMOX1, the gene for the antioxidant and anti-
inflammatory enzyme heme oxygenase (HO)-1 (Tjoa, et al., 2003). HO-1 cleaves the α-methene 
bridge of heme moiety to produce equimolar amounts of carbon monoxide (CO), bilirubin and 
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iron (Abraham and Kappas, 2008;  Ndisang et al., 2004). CO and bilirubin are known to alleviate 
apoptosis, necrosis, inflammation and oxidative stress (Bainbridge et al., 2006;  Baranano et al., 
2002;  Jadhav et al., 2008;  Ndisang and Jadhav, 2009;  Stocker et al., 1987), while iron 
enhances the synthesis of the antioxidant ferritin (Balla et al., 1992;  Hintze and Theil, 2005). 
Several lines of evidence suggest that HO-1 is a key regulator during pregnancy (Vince, et al., 
1995). For example, HO-1 polymorphisms have been associated with incidence of idiopathic 
recurrent miscarriages in women (Denschlag et al., 2004). In addition, placentas from human 
pathologic pregnancies including spontaneous abortion, choriocarcinoma, and hydatidiform mole, 
express lower levels of HO-1 compared with normal pregnancies (Zenclussen et al., 2003), 
further suggesting that HO expression is required to support successful pregnancy in humans. 
Based on the observed increase in HMOX1 expression with BDE-47 and previously published 
reports, we suggest that HMOX1 may play a protective role against BDE-47-stimulated 
oxidative stress and inflammation in placental cells. 
 Among other genes, expression of PTGS2, the gene for COX-2, was highly induced in 
our study.  COX-2 is a rate-limiting enzyme in the synthesis of prostaglandins (Shanmugam et 
al., 2006). Increased PTGS2 mRNA expression and prostaglandins in gestational compartments 
have been associated with preterm birth (Cox et al., 1993;  Mijovic et al., 1998). In addition, 
prostaglandin E2 (PGE2) has been reported to regulate trophoblast migration and invasion that 
are critical for proper placentation (Biondi et al., 2006;  Horita et al., 2007;  Nicola et al., 2005). 
Given the critical roles for prostaglandins in pregnancy, further study could investigate the 
effects of BDE-47 on PGE2 production and trophoblast cellular function.  
Expression of DHCR24, the gene for 3β-hydroxysterol-D24 reductase, was decreased in 
the present study. Because DHCR24 catalyzes the last step in cholesterol biosynthesis, reduced 
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DHCR24 expression could potentially interfere with synthesis of steroid hormones, including  
progesterone, which plays critical roles in maintenance of pregnancy (Luu et al., 2014;  Tetz et 
al., 2013). Moreover, DHCR24 expression was downregulated in the IUGR placentas (Diplas et 
al., 2009). The increased mRNA expression of PRNP, the gene for prion protein, is consistent 
with BDE-47-stimulated ROS production because PNRP is known to protect cells from oxidative 
damage and to prevent apoptosis (Liang et al., 2006;  Watt et al., 2005). Potential roles for PRNP 
during pregnancy are largely unknown, but it was recently reported that PRNP is highly 
expressed in placentas from preeclamptic pregnancies (Hwang et al., 2010). Whether the BDE-
47-stimulated DHCR24 and PRNP gene responses observed in the present study are relevant to 
human pregnancy requires additional experiments beyond the scope of the present study. 
Expression of genes involved in GSH redox cycling such as SLC7A11, SRXN1, GSR, 
GCLM, and GPX1 was also differentially regulated with BDE-47 treatment in HTR-8/SVneo 
cells. SLC7A11 encodes an amino acid antiporter that mediates the exchange of extracellular L-
cystine and intracellular L-glutamate across the cellular plasma membrane, which is critical to 
glutathione production and oxidative protection (Lewerenz et al., 2013). SRXN1 codes for 
sulfiredoxin 1, which plays a role in reduction of oxidative modification on proteins (Findlay et 
al., 2005), and GPX1 is the gene for gluthathione peroxidase 1, which catalyzes the reduction of 
hydroperoxides and lipid peroxides using GSH as a reductant (Chance et al., 1979). Increased 
expression of SRNX1 and GPX1 in the present study may implicate increased oxidation of 
proteins and lipids in BDE-47-treated cells by BDE-47-stimulated ROS generation (Park, et al., 
2014), although further studies should be conducted to measure oxidation of proteins and lipids. 
Expression of SLC7A11 was stimulated with BDE-47 treatment, suggesting increased cellular 
uptake of cystine as a substrate for intracellular GSH production. The first step of GSH synthesis 
115 
 
is rate-limiting and is catalyzed by glutamate-cysteine ligase composed of a glutamate-cysteine 
ligase catalytic subunit (GCLC)  and a glutamate-cysteine ligase modifier subunit (GCLM) (Lu, 
2009). Expression of GCLM was stimulated with BDE-47 treatment, consistent with the 
augmented GSH concentrations observed in HTR-8/SVneo cells. Gluthathione reductase (GSR) 
is an antioxidant enzyme that catalyzes the reduction of GSH disulfide by NADPH (Harvey et 
al., 2009), leading to increased availability of reduced GSH. mRNA expression of GSR was 
reduced by BDE-47 treatmentalso in agreement with the changes in cellular redox status. 
Expression of the genes identified in the PCR array are either directly or indirectly regulated by 
Nrf2 (Ma, 2013;  Taylor et al., 2008;  Wakabayashi et al., 2010), suggesting that Nrf2 may play 
a critical role in the regulation of BDE-47-mediated cellular defense responses.  
Consistent with array results showing differential expression of redox-sensitive genes, the 
present study found increased ARE reporter activity in BDE-47-exposed HTR-8/SVneo cells, 
indicating Nrf2 induction in response to BDE-47. To defend against exogenous toxicants and 
injury, cells express a variety of cytoprotective and detoxifying enzymes regulated by redox-
sensitive transcription factors that bind to the antioxidant response element (ARE) in the 
promoter. Nrf2 is a well-known redox-sensitive transcription factor that binds to ARE and 
activates the ARE-mediated gene expression (Itoh et al., 1997;  Motohashi and Yamamoto, 
2004;  Osburn et al., 2006). BDE-47 stimulates increased ROS generation (Park, et al., 2014), 
and ROS  can oxidize cysteine residues on Nrf2 inhibitor Keap1, leading to conformational 
changes in Keap1, Nrf2 release, and translocation of Nrf2 to activate ARE-dependent gene 
expression (Rushmore et al., 1991) as a defensive mechanism to protect cells from ROS and 
inflammation. Although there have been extensive studies on the protective role of Nrf2 against 
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carcinogens and xenobiotics in vitro and in vivo (Fahey et al., 2002;  Kensler et al., 2007), this is 
the first study to report BDE-47-stimulated activation of Nrf2 pathways in human placental cells. 
In limited studies, increased Nrf2 activity was reported in cytotrophoblasts and EVTs 
from placentae with IUGR or PE (Kweider, et al., 2012;  Wruck, et al., 2009). In addition, 
genome-wide transcriptional profiling of preeclamptic and normal pregnancies showed that the 
Nrf2-mediated oxidative stress response was dysregulated in PE (Chigusa, et al., 2012;  Loset, et 
al., 2011). Furthermore, decreased expression of HO-1, a hallmark of Nrf2 activation, was 
associated with lower cell motility and trophoblast invasion (Bilban et al., 2009). Together, these 
data imply that Nrf2 may play a critical role in the regulation of trophoblast cellular function and 
invasion, and that dysregulation of Nrf2 may contribute to the etiology and progression of birth 
complications.  
Our results clearly show that pretreatment with the Nrf2 inducer tBHQ or sulforaphane 
suppressed BDE-47-stimulated IL-6 production in HTR-8/SVneo cells. In addition, induction of 
Nrf2 with tBHQ pretreatment suppressed BDE-47-stimulated NF-κB transactivation. NF-κB is a 
transcription factor that plays a crucial role in immune and inflammatory response (Blackwell 
and Christman, 1997). Although we did not assess a causal relationship between BDE-47-
stimulated NF-κB activity and IL-6 release, NF-κB is well known to regulate the transcription of 
IL-6 (Blackwell and Christman, 1997;  Reuter, et al., 2010). As such, decreased NF-κB activity  
partially explains the anti-inflammatory effect of tBHQ in the present study. Consistent with our 
findings, many studies have provided evidence of an anti-inflammatory effect of Nrf2 in a 
variety of experimental models (Khor, et al., 2006;  Rangasamy, et al., 2004;  Rangasamy, et al., 
2005;  Thimmulappa, et al., 2006). For example, tBHQ has shown to decrease NF-κB activation, 
inflammatory cytokines production (TNF-α, IL-1β, and IL-6), COX-2 expression, and PGE2 
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release in vivo and in vitro (Jin et al., 2010;  Khodagholi and Tusi, 2011;  Koh et al., 2009). 
Another Nrf2 inducer, sulforaphane, has shown to reduce DNA binding of NF-κB and decrease 
generation of nitric oxide (NO), PGE2 and TNF-α in Raw 264.7 murine macrophages (Heiss et 
al., 2001). However, to the best of our knowledge, the present study is the first to report the 
protective role of Nrf2 activation on toxicant-stimulated inflammatory responses in human 
placental cells. 
A wide range of natural and synthetic small molecules including tBHQ and sulforaphane 
induce Nrf2 activity (Ma, 2013). Although the precise mechanism regarding the anti-
inflammatory activity of Nrf2 inducers remains elusive, it is suggested that the anti-inflammatory 
properties might result from augmentation of cellular antioxidant systems via up-regulation of 
the Nrf2 signaling pathway and inhibition of the NF-κB signaling pathway (Jin, et al., 2011;  
Khodagholi and Tusi, 2011). The augmented GSH concentrations and increased antioxidant gene 
expression observed in the present study are consistent with a role of Nrf2 inducers on increased 
cellular antioxidative capacity in previous studies (Alfieri et al., 2011;  Hara et al., 2003). In 
addition, our results showed that suppression of BDE-47-stimulated NF-κB transactivation by 
tBHQ pretreatment, implicating cross talk between the Nrf2 and NF-κB signaling pathways.  
The Nrf2 and NF-κB signaling pathways interact at several points through mechanisms of 
regulation ranging from direct effects on the transcription factors themselves to protein–protein 
interactions and second-messenger effects on target genes (Wakabayashi, et al., 2010). It is 
suggested that Nrf2 may reduce available co-activator levels and promote recruitment of a co-
repressor, leading to interruption of NF-κB binding to DNA. In addition, Nrf2 target genes such 
as HO-1, NQO1, and thioredoxin (TRX) are able to influence NF-κB activity (Wakabayashi, et 
al., 2010). Moreover, Nrf2 interferes with NF-κB inflammatory signaling pathways through the 
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maintenance of cellular redox status because NF-κB is activated in the oxidizing environment 
(Kabe et al., 2005). Our results are in agreement with this model of Nrf2 and NF-κB interactions, 
showing that tBHQ stimulated mRNA expression of HMOX1, the gene for HO-1, and 
augmented GSH production concomitant with suppression of NF-κB reporter activity. Based on 
our findings and other relevant reports, the following model is suggested: that BDE-47-
stimulated ROS may activate Nrf2 to restore cellular redox status to a less oxidizing environment 
via increased cellular antioxidant capacity, resulting in suppression of NF-κB activity, and, in 
turn, decreasing IL-6 production in HTR-8/SVneo cells. In addition, expression of the Nrf2 
target protein HO-1 may modulate NF-kB activity through the action of bilirubin and free iron 
that are produced by HO-1 activity (Alam et al., 1999;  Jun et al., 2006;  Pae et al., 2006;  Seldon 
et al., 2007;  Soares et al., 2004;  Tenhunen et al., 1968). Further studies could investigate the 
effect of HO-1 induction or its products on inflammation induced by BDE-47 treatment in HTR-
8/SVneo cells. However, we shoud note that the observed anti-inflammatory effects may 
originate from not a single mechanism, but from multiple mechanisms involving various proteins 
and signaling molecules (Kabe, et al., 2005). Moreover, the direct dependance of the anti-
inflammatory effect on Nrf2 should be tested using genetic knockdown approaches such as 
RNAi.  
In summary, BDE-47, a predominant flame retardant chemical found in human tissues, 
activates Nrf2-dependent oxidative stress responses in human first trimester EVTs as indicated 
by differential expression of oxidative stress genes, stimulated ARE reporter activity, and 
augmented production of GSH. Our results provide evidence that Nrf2 activation by chemical 
inducers suppressed BDE-47-stimulated IL-6 production in human placental cells with 
stimulated ARE reporter activity, reduced NF-κB reporter activity, increased GSH production, 
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and stimulated expression of antioxidant genes compared to non-Nrf2 inducer pretreated groups. 
This is the first study to show that BDE-47 activated Nrf2-dependent oxidative stress pathways 
in human first trimester EVTs and to link PBDE-stimulated pro-inflammatory responses with 
Nrf2 signaling pathways. Because proper trophoblast function is necessary for placental 
development and successful pregnancy, and dysregulation of inflammatory responses are 
associated with altered trophoblast invasion and placental dysfunction, further investigation of 
the impact of BDE-47 on trophoblast function is warranted. In addition, further studies about the 
role of Nrf2 on BDE-47-stimulated responses will be needed to confirm its protective effects and 
to consider Nrf2 as a potential therapeutic target to prevent adverse birth outcomes. 
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Figure 4.1. BDE-47-stimulated intracellular GSH production in HTR-8/SVneo cells.  
A) HTR-8/SVneo cells were exposed to NT (non-treated control), solvent control (0.07% v/v 
DMSO) or BDE-47 treatment for 24 h, and then GSH levels were quantified. B) Time-course of 
GSH levels. Bars represent means±SEM (n=3 experiments). Each experiment was performed in 
triplicate.*P<0.05, significant compared to solvent control within same time point. 
#
P<0.05, 
significantly different from each other. 
&
P<0.05, different from NT, solvent control, and BDE-47 
treated groups within same time point. 
A 
B 
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Figure 4.2.  BDE-47-stimulated ARE reporter activity in HTR-8/SVneo cells.  
HTR-8/SVneo cells were exposed to solvent control (0.7% v/v DMSO) or BDE-47 treatment for 
6 or 24 h, and then ARE reporter activity was assessed. Data are presented as means±SEM fold 
change over solvent control (dashed line) for each respective time point. To derive fold changes, 
Firefly luciferase relative light unit (RLU) values were first normalized to Renilla luciferase to 
compensate for cell number and transfection efficiency, then fold changes were calculated 
relative to solvent control for each time point (n=3 experiments). Each experiment was 
performed in triplicate.*P<0.05, significant compared to solvent control within same time point. 
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Figure 4.3. BDE-47 effects on HTR-8 cell mRNA expression of genes previously identified with 
a targeted gene expression array.  
A) mRNA expression of HMOX1, PTGS2, PRNP, and DHCR24. B) mRNA expression of 
SLC7A11, SRXN1, GSR, GCLM, and GPX1. HTR-8/SVneo cells were exposed to solvent 
control (0.7% v/v DMSO) or BDE-47 treatment for 24 h. Then, mRNA expression of redox-
sensitive genes was quantified by qRT-PCR. Bars represent means±SEM (n=3 experiments). 
Each experiment was performed in triplicate.*P<0.05, significant compared to solvent control. 
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Figure 4.4.  Effect of pretreatment with Nrf2 inducers on BDE-47-stimulated ARE reporter 
activity in HTR-8/SVneo cells.  
A) Cells were pretreated with TBHQ for 1 h prior to subsequent incubation without or with 
BDE-47 for 24 h. Then, ARE reporter activity was quantified.  B) Cells were pretreated with 
sulforaphane for 24 h h prior to subsequent incubation without or with BDE-47 for 24 h. Then, 
ARE reporter activity was measured. Data are presented as means±SEM fold change over 
control (dashed line, No BDE-47 with 0 µM TBHQ). To derive fold changes, Firefly luciferase 
relative light unit (RLU) values were first normalized to Renilla luciferase to compensate for cell 
number and transfection efficiency, then fold changes were calculated relative to control (n=3 
experiments). Each experiment was performed in triplicate. *P<0.05, compared to control. 
&
P<0.05, compared to 0, 5, and 10 µM TBHQ within 20 µM BDE-47 treatment (A) or compared 
to 0, 5, and 7.5 µM sulforaphane within 20 µM BDE-47 treatment (B). 
#
P<0.05, significantly 
different from each other. 
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Figure 4.5. Effect of pretreatment with the Nrf2 inducer TBHQ on BDE-47-stimulated GSH 
production in HTR-8/SVneo cells.  
Cells were pretreated with TBHQ, and then exposed to solvent control (No BDE-47, 0.7% v/v 
DMSO) or BDE-47 for 24h. GSH levels were quantified using a luminescence-based assay (n=3 
experiments). Each experiment was performed in triplicate. *P<0.05, compared to control 
(dashed line, No BDE-47 with 0 µM TBHQ).
+
P<0.05,compared to 0 µM TBHQ within 20 µM  
BDE-47 treatment.  
&
P<0.05, compared to 0, 10, and 20 µM TBHQ within 20 µM BDE-47 
treatment. 
#
P<0.05, significantly different from each other. 
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Figure 4.6. Effect of pretreatment with the Nrf2 inducer TBHQ on mRNA expression of 
antioxidant genes.  
HTR-8/SVneo cells were pretreated with TBHQ, and then exposed to solvent control (No BDE-
47, 0.7% v/v DMSO) or BDE-47 for 24h. Bars represent means±SEM fold change over control 
(dashed line, No BDE-47 with 0 µM TBHQ). The target gene expression from each sample was 
first normalized to the housekeeping gene B2M, and then fold changes were calculated relative 
to the normalized control (n=3 experiments). A) mRNA expression of HMOX1. B) mRNA 
expression of GCLM. *P<0.05, compared to control. 
#
P<0.05, significantly different from each 
other. 
&
P<0.05, compared to 20 µM BDE-47 with 0 µM TBHQ. 
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Figure 4.7. Effect of pretreatment with Nrf2 inducers on BDE-47-stimulated IL-6 release from 
HTR-8/SVneo cells.  
A) HTR-8/SVneo cells were pretreated with TBHQ for 1 h prior to treatment with BDE-47 for 
24 h. B) After treatment with sulforaphane for 24 h, cells were exposed to solvent control (No 
BDE-47, 0.7% v/v DMSO) or BDE-47 for 24h. Then, IL-6 levels were quantified using ELISA. 
Bars represent means±SEM (n=3 experiments). Each experiment was performed in triplicate. 
*P<0.05, compared to No BDE-47 with 0 µM TBHQ or sulforaphane. 
#
P<0.05, significantly 
different from each other.
 &
P<0.05, compared to 20 µM BDE-47 with 0 or 5 µM sulforaphane. 
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Figure 4.8. Effect of pretreatment with TBHQ on BDE-47-induced NF-κB reporter activity in 
HTR-8/SVneo cells.  
HTR-8/SVneo cells were pretreated with TBHQ for 1 h prior to treatment with BDE-47 for 24 h. 
After incubation with BDE-47, NF-κB reporter activity was quantified. Data are presented as 
means±SEM fold change over control (dashed line, No BDE-47 with 0 µM TBHQ). To derive 
fold changes, Firefly luciferase relative light unit (RLU) values were first normalized to Renilla 
luciferase to compensate for cell number and transfection efficiency, then fold changes were 
calculated relative to control (n=3 experiments). *P<0.05, compared to control. 
#
P<0.05, 
significantly different from each other. 
&
P<0.05, compared to 20 µM BDE-47 with 50 µM 
TBHQ. 
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Appendix 4.1. Oxidative stress response array1 
 
Symbol Description 
4 h 24 h 
Fold 
change 
P value 
Fold 
change 
P value 
ALB Albumin 0.79 0.85728 0.46 0.24648 
ALOX12 Arachidonate 12-lipoxygenase 1.07 0.91189 1.16 0.72132 
AOX1 Aldehyde oxidase 1 0.81 0.52586 2.95 0.00028 
APOE Apolipoprotein E 0.87 0.66628 0.56 0.01941 
ATOX1 ATX1 antioxidant protein 1 homolog (yeast) 0.97 0.71154 0.68 0.00007 
BNIP3 BCL2/adenovirus E1B 19kDa interacting protein 3 1.00 0.96417 1.14 0.10141 
CAT Catalase 1.01 0.91189 0.81 0.00109 
CCL5 Chemokine (C-C motif) ligand 5 0.56 0.54991 1.94 0.31119 
CCS Copper chaperone for superoxide dismutase 1.10 0.47196 1.30 0.01038 
CYBB Cytochrome b-245, beta polypeptide NA NA NA NA 
CYGB Cytoglobin 0.70 0.33950 0.95 0.81152 
DHCR24 24-dehydrocholesterol reductase 0.95 0.74263 0.26 0.00000 
DUOX1 Dual oxidase 1 0.93 0.88184 1.61 0.14186 
DUOX2 Dual oxidase 2 0.75 0.53378 1.18 0.58108 
DUSP1 Dual specificity phosphatase 1 3.04 0.05355 1.43 0.26027 
EPHX2 Epoxide hydrolase 2, cytoplasmic 0.58 0.29158 0.66 0.15208 
EPX Eosinophil peroxidase 0.78 0.63692 0.84 0.58108 
FOXM1 Forkhead box M1 0.94 0.63692 0.88 0.13214 
FTH1 Ferritin, heavy polypeptide 1 1.02 0.90003 1.74 0.00016 
GCLC Glutamate-cysteine ligase, catalytic subunit 0.83 0.54750 1.54 0.05160 
GPX1 Glutathione peroxidase 1 1.01 0.90003 1.85 0.00001 
GPX2 Glutathione peroxidase 2 (gastrointestinal) 0.95 0.91189 1.15 0.72132 
GPX3 Glutathione peroxidase 3 (plasma) 1.05 0.47196 0.62 0.00000 
GPX4 
Glutathione peroxidase 4 (phospholipid 
hydroperoxidase) 
1.04 0.65208 0.63 0.00001 
GPX5 
Glutathione peroxidase 5 (epididymal androgen-
related protein) 
NA NA NA NA 
GSR Glutathione reductase 1.35 0.29964 2.08 0.00141 
GSS Glutathione synthetase 1.01 0.95134 1.22 0.03016 
GSTP1 Glutathione S-transferase pi 1 1.12 0.36484 1.04 0.58108 
GSTZ1 Glutathione transferase zeta 1 1.04 0.74263 1.02 0.74909 
HSPA1A Heat shock 70kDa protein 1A 0.39 0.29158 1.03 0.92751 
KRT1 Keratin 1 NA NA NA NA 
LPO Lactoperoxidase NA NA NA NA 
MB Myoglobin 1.23 0.87559 0.63 0.56381 
MBL2 Mannose-binding lectin (protein C) 2, soluble NA NA NA NA 
MPO Myeloperoxidase NA NA NA NA 
MPV17 MpV17 mitochondrial inner membrane protein 0.93 0.29964 1.04 0.36442 
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MSRA Methionine sulfoxide reductase A 0.86 0.41372 1.61 0.00162 
MT3 Metallothionein 3 NA NA NA NA 
NCF1 Neutrophil cytosolic factor 1 0.40 0.29964 0.51 0.22023 
NCF2 Neutrophil cytosolic factor 2 0.91 0.84078 1.20 0.52355 
NOS2 Nitric oxide synthase 2, inducible 0.76 0.41372 1.10 0.67158 
NOX4 NADPH oxidase 4 0.74 0.65208 0.91 0.80238 
NOX5 NADPH oxidase, EF-hand calcium binding domain 5 1.51 0.42014 2.24 0.12118 
NUDT1 
Nudix (nucleoside diphosphate linked moiety X)-type 
motif 1 
0.95 0.65208 0.97 0.68372 
PDLIM1 PDZ and LIM domain 1 0.89 0.42014 0.66 0.00137 
PRDX1 Peroxiredoxin 1 0.92 0.66628 0.79 0.09428 
PRDX2 Peroxiredoxin 2 0.91 0.29964 0.71 0.00016 
PRDX3 Peroxiredoxin 3 0.96 0.76440 0.83 0.08061 
PRDX4 Peroxiredoxin 4 1.07 0.76440 1.69 0.00322 
PRDX5 Peroxiredoxin 5 0.98 0.81849 1.08 0.13692 
PRDX6 Peroxiredoxin 6 0.98 0.75656 1.15 0.00511 
PRNP Prion protein 1.06 0.71154 2.43 0.00001 
PTGS1 
Prostaglandin-endoperoxide synthase 1 (prostaglandin 
G/H synthase and cyclooxygenase) 
0.02 0.06755 0.02 0.00621 
PTGS2 
Prostaglandin-endoperoxide synthase 2 (prostaglandin 
G/H synthase and cyclooxygenase) 
2.18 0.15622 2.90 0.00353 
RNF7 Ring finger protein 7 1.15 0.54750 1.98 0.00089 
SELS Selenoprotein S 1.17 0.15622 1.68 0.00001 
SEPP1 Selenoprotein P, plasma, 1 0.75 0.74263 2.27 0.14876 
SFTPD Surfactant protein D 0.59 0.29158 1.07 0.76998 
SIRT2 Sirtuin 2 0.89 0.42596 0.95 0.61995 
SOD1 Superoxide dismutase 1, soluble 0.98 0.90003 0.92 0.32389 
SOD2 Superoxide dismutase 2, mitochondrial 0.88 0.29964 1.04 0.59632 
SOD3 Superoxide dismutase 3, extracellular NA NA NA NA 
SQSTM1 Sequestosome 1 1.10 0.42596 2.66 0.00000 
SRXN1 Sulfiredoxin 1 0.90 0.41372 2.92 0.00000 
TPO Thyroid peroxidase NA NA NA NA 
TTN Titin NA NA NA NA 
TXNRD2 Thioredoxin reductase 2 1.03 0.88184 1.09 0.56381 
UCP2 Uncoupling protein 2 (mitochondrial, proton carrier) 0.81 0.29158 0.66 0.00170 
AKR1C2 
Aldo-keto reductase family 1, member C2 
(dihydrodiol dehydrogenase 2; bile acid binding 
protein; 3-alpha hydroxysteroid dehydrogenase, type 
III) 
1.20 0.84078 2.81 0.07325 
BAG2 BCL2-associated athanogene 2 1.02 0.87559 1.48 0.00013 
FHL2 Four and a half LIM domains 2 1.63 0.03733 1.91 0.00023 
GCLM Glutamate-cysteine ligase, modifier subunit 0.93 0.54750 1.90 0.00001 
GLA Galactosidase, alpha 0.92 0.56400 1.11 0.26027 
HMOX1 Heme oxygenase (decycling) 1 1.15 0.33950 4.72 0.00000 
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HSP90AA1 
Heat shock protein 90kDa alpha (cytosolic), class A 
member 1 
0.91 0.29964 1.68 0.00001 
LHPP 
Phospholysine phosphohistidine inorganic 
pyrophosphate phosphatase 
0.92 0.54991 0.91 0.31780 
NCOA7 Nuclear receptor coactivator 7 1.16 0.29158 1.59 0.00016 
NQO1 NAD(P)H dehydrogenase, quinone 1 0.83 0.29964 1.23 0.09026 
PTGR1 Prostaglandin reductase 1 0.91 0.29158 0.88 0.02136 
SLC7A11 
Solute carrier family 7 (anionic amino acid transporter 
light chain, xc- system), member 11 
1.25 0.29964 6.71 0.00000 
SPINK1 Serine peptidase inhibitor, Kazal type 1 NA NA NA NA 
TRAPPC6A Trafficking protein particle complex 6A 1.05 0.71154 1.13 0.15208 
TXN Thioredoxin 1.01 0.94674 1.61 0.00016 
TXNRD1 Thioredoxin reductase 1 0.90 0.65208 1.97 0.00123 
1HTR-8 cells were treated with DMSO (0.7% v/v; solvent control) or 20 µM MEHP for 4 or 24 h (n=3 
experiments).  The Oxidative Stress Response qRT-PCR Array (SABiosciences; Valencia, CA) was used 
to explore changes in gene expression as described in the “Materials and Methods” section.  Fold changes 
and p-values are shown for all genes and time points tested.  NA= CT value of above 40 for one or more 
experiments, suggesting low level expression of that gene. 
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 DISCUSSION CHAPTER 5.
Polybrominated diphenyl ethers (PBDEs) are synthetic flame-retardants that have been 
used in textiles, plastics, building materials and insulation (Miller et al., 2009). Due to 
widespread use and bioaccumulation of PBDEs, human exposure to PBDEs increased 
exponentially over recent decades (Hites, 2004). Despite distribution of PBDEs to human 
gestational compartments during pregnancy (Frederiksen et al., 2009a;  Frederiksen et al., 
2009b;  Miller, et al., 2009;  Miller et al., 2012), studies of mechanisms by which PBDEs act on 
gestational tissues during pregnancy are limited. This thesis explores mechanisms by which 
BDE-47-stimulated reactive oxygen species (ROS) may activate inflammatory pathways in 
human first trimester placental cells. As such, this is the first study to show that BDE-47, a 
prevalent PBDE congener, induced oxidative stress responses such as ROS formation, 
modification of redox-sensitive gene expression and activation of Nrf2, a master regulator of 
oxidative stress, in a human first trimester extravillous trophoblast (EVT) cell line, HTR-
8/SVneo (Figure 5.1). In addition, BDE-47 stimulated production of inflammatory mediators 
including the cytokines interleukin (IL)-6, IL-8, and prostaglandin E2 (PGE2) in HTR-8/SVneo 
cells (Figure 5.1). Finally, our results demonstrated signal transduction crosstalk between the 
oxidative stress and inflammatory pathways, showing that BDE-47-stimulated IL-6 and PGE2 
release were suppressed by treatment with antioxidants and/or Nrf2 inducers (Figure 5.1).  
Cytokines and prostaglandins are considered key players in reproductive processes 
including the establishment and maintenance of pregnancy, and the initiation of labor (Bowen et 
al., 2002;  Gibb, 1998;  Goldenberg and Andrews, 1996;  Gomez et al., 1997;  Hansen et al., 
1999;  Khan et al., 2008;  Kniss, 1999;  Mitchell et al., 1995;  Orsi, 2008). There have been 
extensive studies suggesting that improper regulation of the inflammatory networks may lead to 
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adverse pregnancy outcomes such as miscarriage, preeclampsia, intrauterine growth restriction 
(IUGR) and preterm labor (Orsi and Tribe, 2008;  Tjoa et al., 2004). However, studies about the 
roles of cytokines and prostaglandins in first trimester placenta are limited because many studies 
focused on their roles in the biological processes of birth, including dynamic cervical remodeling 
(Norman et al., 2007), uterine contractility (Baggia et al., 1996), and gestational membrane 
rupture (Keelan et al., 2003). In addition, increased production of cytokines and prostaglandins 
has been used as an indicator of pathologic activation of pro-inflammatory pathways by bacterial 
vaginosis (Flynn et al., 1999;  Leitich et al., 2003) or intrauterine infection (Goldenberg et al., 
2008;  Romero et al., 2001) in association with increased risk of preterm labor. Although adverse 
birth outcomes often manifest during the later stages of pregnancy, there is a growing body of 
literature suggesting that adverse obstetrical outcomes may result from abnormal placentation 
and placental dysfunction occurring in early pregnancy (Anton et al., 2012;  Ness and Sibai, 
2006). 
It has been suggested that defects in EVT cellular function involving dysregulation of 
inflammatory mediators in placenta contribute to the placental dysfunction seen in IUGR, 
preeclampsia, and preterm birth (Arechavaleta-Velasco et al., 2002;  Goldenberg et al., 2000;  
Goncalves et al., 2002;  Lamont, 2003;  von Dadelszen and Magee, 2002;  von Dadelszen et al., 
2003). Histologic examination found evidence of localized inflammation (histologic 
chorioamnionitis) in 85% of placentae from spontaneous preterm births delivered at 28 weeks 
gestation (Yoon et al., 2000), with higher rates of placental ischemia and abnormal placentation 
compared with controls at term (Germain et al., 1999;  Kim et al., 2003). A recent study reported 
that LPS increases production of IL-8 and IL-6 and decreases invasion activity in HTR-8/SVneo 
cells (Anton, et al., 2012). Moreover, a few studies showed that dysregulation of IL-6, IL-8, and 
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PGE2 changed trophoblast cellular functions such as proliferation, migration, and invasion in  
vitro (Biondi et al., 2006;  Dubinsky et al., 2010;  Horita et al., 2007b;  Jovanovic et al., 2010;  
Jovanovic and Vicovac, 2009;  Nicola et al., 2005a). Our results clearly show that treatment with 
BDE-47 stimulated proinflammatory cytokines IL-6 and IL-8 at protein and mRNA levels in 
HTR-8/SVneo cells. Moreover, BDE-47 treatment induced COX activity leading to increased 
PGE2 release from HTR-8/SVneo cells. Although interaction between BDE-47 exposure and 
inflammation have been implicated in limited studies (Ashwood et al., 2009;  Peltier et al., 
2012), this study is the first to show the activation of inflammatory pathways by BDE-47 in 
human first trimester placental cells.  
In the present study, we proposed ROS as a critical regulator of BDE-47-stimulated 
inflammatory pathways in human placental cells. Our findings showed that treatment with BDE-
47 stimulated ROS in HTR-8/SVneo cells, and that BDE-47-induced IL-6 and PGE2 production 
was suppressed by antioxidant treatment, indicating that ROS play a role in the initiation of 
inflammatory responses in response to BDE-47 exposure. It has been reported that ROS can 
regulate signal transduction pathways in mammalian cells as second messengers (Khan and 
Wilson, 1995). Similar to our results, ROS have been shown to activate production of IL-6 and 
IL-8 (Frossi et al., 2003;  Verhasselt et al., 1998), and cyclooxygenase (COX) expression and/or 
activity (Feng et al., 1995;  Kiritoshi et al., 2003;  Martinez-Revelles et al., 2013). Although 
mechanisms of regulation of inflammatory response by ROS are not fully understood, 
involvement of the redox-sensitive transcription factor NF-κB has been implicated (Reuter et al., 
2010). NF-κB plays a crucial role in immune and inflammatory response, regulating expression 
of a large number of genes, including those for cytokines, growth factors, adhesion molecules, 
immunoreceptors, and acute-phase proteins (Blackwell and Christman, 1997). Of direct 
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relevance to the present study, NF-κB has been shown to regulate expression of IL-6, IL-8 
(Blackwell and Christman, 1997;  Reuter, et al., 2010) and COX gene expression (Chiang et al., 
2003;  Crofford et al., 1997). Several lines of evidence suggest a role for ROS in activation of 
NF-κB, and antioxidants inhibit NF-κB activation in vitro and in vivo (Blackwell and Christman, 
1997). Our results showed that NF-κB reporter activity increased with BDE-47 treatment 
concomitant with increases in IL-6, IL-8, COX-2 expression, and COX activity, implicating the 
involvement of NF-κB on BDE-47-stimulated inflammatory responses. However, our findings 
are correlative only, and further study will be needed to demonstrate the causal relationship 
between NF-κB activation and the observed inflammatory responses.  
In addition to NF-κB, other redox-sensitive transcription factors may play a role in the 
regulation of BDE-47-stimulated inflammatory pathways in the present study. The promoter 
region of the IL-6 and IL-8 genes contains multiple regulatory elements including NF-κB, 
antioxidant response element (ARE)/ARE-like element, and activator protein (AP)-1 (Dendorfer 
et al., 1994;  Roebuck, 1999). The promoter region of PTGS2 gene also contains various cis-
acting elements such as NF-κB, AP-1, cAMP response element (CRE), and NF-IL6 (Inoue et al., 
1995). Our findings showed that ARE reporter activity increased with BDE-47 treatment 
coinciding with increases in IL-6, IL-8, and COX-2 expression in HTR-8/SVneo cells. Although 
the protective role of Nrf2 activation against oxidative stress and inflammation is well 
established, it is suggested that Nrf2 may play a role in activation of inflammatory genes. For 
example, it is reported that Nrf2 induces IL-6 and IL-8 expression via binding to ARE in vivo 
and in vitro (Wruck et al., 2011;  Zhang et al., 2005). Moreover, PTGS2 is a known Nrf2 target 
gene (Tufekci et al., 2011) and its expression is regulated by Nrf2/ARE signaling pathways in 
various experimental models (Luo et al., 2011;  Rojo et al., 2010;  Wang et al., 2010). Further 
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study is warranted to examine the role Nrf2 in the activation of BDE-47-stimulated 
inflammation. Furthermore, the involvement of other redox-sensitive transcription factors such 
as AP-1 could be investigated, considering the observed ROS formation by BDE-47 treatment 
(Park et al., 2014). 
ROS overproduction has been a common contributing factor to toxicity of PBDEs as 
detected with in vitro systems (He et al., 2008;  Reistad and Mariussen, 2005;  Shao et al., 2008;  
Yan et al., 2011). The present study provides new information that BDE-47 increased ROS 
generation in the human trophoblast cell line HTR-8/SVneo. Moreover, BDE-47 decreased 
mitochondrial membrane potential, indicating mitochondrial dysfunction (Brand and Nicholls, 
2011). Because mitochondrial defects can lead to enhanced mitochondrial production of ROS 
(Sohal et al., 1995), we suggest that the BDE-47-stimulated ROS in HTR-8/SVneo cells may 
have originated from mitochondria (Park, et al., 2014). Similar to our results, a few studies 
reported reduced mitochondrial membrane potential (Shao, et al., 2008;  Yan, et al., 2011), 
implicating the involvement of mitochondria on BDE-47-stimulated ROS. However, the 
mechanisms of BDE-47-stimulated ROS formation is still not clear. Specifically, the 
mitochondrial origin of BDE-47-stimulated ROS has not been verified experimentally yet. In 
addition, we don’t know whether BDE-47-stimulated ROS formation is a direct result from its 
exposure or a secondary response followed by signaling cascades. Moreover, not BDE-47, but its 
reactive metabolites may play a role in the activation of BDE-47-stimulated responses. It was 
recently reported that hydroxylated PBDEs may be more toxic than the parent PBDEs 
(Dingemans et al., 2008;  Feo et al., 2013). Oxidative stress by hydroxylated BDE-47, such as 
formation of ROS and DNA damage, has also been reported (An et al., 2011;  Ji et al., 2011). 
Finally, BDE-47-stimulated ROS could originate from multiple sources, not a single source. In 
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fact, Reistad and Mariussen (2005) reported that BDE-47 enhanced the production of ROS, 
potentially through NADPH oxidase activation in human granulocytes, suggesting complex 
pathways of BDE-47-mediated ROS formation.  
In the present study, we explored the ability of Nrf2 to inhibit BDE-47-stimulated 
inflammatory responses in HTR-8/SVneo cells. Nrf2 is a well-known redox-sensitive 
transcription factor that binds to antioxidant response element (ARE) and activates ARE-
mediated gene expression (Itoh et al., 1997;  Motohashi and Yamamoto, 2004;  Osburn et al., 
2006), resulting in the upregulation of phase II detoxification enzymes and antioxidant enzymes 
(Kensler et al., 2007).  Therefore, activation of Nrf2 pathways is an important cellular defense 
mechanism against exogenous toxins and injury. Our results clearly showed that treatment with 
BDE-47 stimulated Nrf2-mediated oxidative stress responses via differentially regulating 
expression of redox-sensitive genes, augmenting intracellular GSH production, and stimulating 
Nrf2 reporter activity in HTR-8/SVneo cells. These findings not only confirm the previous data 
showing BDE-47-stimulated ROS formation, but also implicate a protective role of Nrf2-
signaling pathways in response to inappropriate inflammatory responses by BDE-47 treatment. 
In addition, there is a growing body of literature reporting anti-inflammatory effect of Nrf2 
activation in vivo and in vitro (Jin et al., 2011;  Jin et al., 2008;  Jin et al., 2009;  Khodagholi and 
Tusi, 2011;  Khor et al., 2006;  Koh et al., 2009;  Rangasamy et al., 2004;  Rangasamy et al., 
2005;  Thimmulappa et al., 2006). Therefore, we tested the hypothesis that activation of Nrf2 by 
Nrf2 inducers may show an anti-inflammatory effect on BDE-47-stimulated pro-inflammatory 
cytokine production in HTR-8/SVneo cells. Indeed, our results, for the first time, showed that 
pretreatment with Nrf2 inducers such as tert-butylhydroquinone (tBHQ) or sulforaphane resulted 
in suppression of BDE-47-stimulated IL-6 release from HTR-8/SVneo cells via upregulating 
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Nrf2 reporter activity, increasing intracellular GSH production, increasing expression of 
antioxidant enzymes, and downregulating NF-κB reporter activity, implicating interplay between 
the NF-κB and Nrf2 pathways. 
Among a wide range of natural and synthetic small molecules that are potent inducers of 
Nrf2 activity (Khodagholi et al., 2010;  Stewart et al., 2003;  Tusi et al., 2010), tBHQ is one of 
the most common. tBHQ has a variety of other pharmacological activities including antioxidant 
and anti-inflammatory potential (Koh, et al., 2009). Although the precise mechanism regarding 
the anti-inflammatory ability of tBHQ remains elusive, the prevailing theory has been that Nrf2 
interferes with inflammatory signaling pathways by inhibiting NF-kB activation through the 
maintenance of cellular redox status. Activation of the NF-kB signaling pathway has been shown 
to be responsive to excess ROS and is important in the generation of inflammation 
(Thimmulappa, et al., 2006). The antioxidant transcription factor Nrf2 plays an important role in 
limiting ROS levels and thereby suppressing the redox-sensitive NF-kB signaling pathway 
involved in inflammation (Itoh, et al., 1997;  Lee and Johnson, 2004). It is therefore implied that 
tBHQ may play an important role in anti-inflammation by a mechanism of augmentation of 
cellular antioxidative responses via up-regulation of the Nrf2 signaling pathway, resulting in 
decreased pro-inflammatory cytokine production via inactivation of NF-kB signaling pathway 
(Jin, et al., 2011). Consistent with this theory,  anti-inflammatory effects of  tBHQ have been 
reported with the evidence of stabilization of Nrf2, suppression of NF-κB expression and 
activity, and suppression of phosphorylation of MAP kinases (p38, ERK1/2, and JNK) (Jin, et 
al., 2011;  Jin et al., 2010;  Jin, et al., 2009;  Khodagholi and Tusi, 2011;  Koh, et al., 2009). In 
addition, our results showed that pretreatment with tBHQ suppressed BDE-47-stimulated IL-6 
release from HTR-8/SVneo cells while upregulating Nrf2 reporter activity, intracellular GSH 
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production, and expression of antioxidant enzymes, and downregulating NF-κB reporter activity. 
Although our study did not investigate changes in cellular redox status by tBHQ treatment, 
tBHQ-stimulated increased cellular production of GSH suggests that tBHQ may help maintain 
cellular redox status by augmenting GSH levels against BDE-47-stimulated ROS. However, the 
mechanism by which tBHQ activates Nrf2 is not entirely understood. It has been shown that 
ROS can activate ARE by stimulating nuclear translocation of the transcription factor Nrf2 (Itoh 
et al., 1999;  Sian et al., 1994). tBHQ-induced ROS production may be a consequence of redox 
cycling from a fully reduced form to an oxidized form as a semiquinone anion radical (Gharavi 
et al., 2007). Oxidative stress-dependent Nrf2 activation by tBHQ has been reported in a few 
studies, showing that antioxidant treatments inhibited tBHQ-induced gene induction in certain 
cell types (Hara et al., 2003;  Itoh, et al., 1999;  Pinkus et al., 1996). On the other hand, it is 
reported that Nrf2-dependent activation of ARE by tBHQ is mediated via an oxidative stress-
independent pathway in IMR32 cells and SH-SY5Y cells (Sian, et al., 1994). The oxidative 
stress-independent ARE activation mediated by Nrf2 is shown to be mediated via various kinase 
pathways such as phosphatidylinositol-3-kinase and p38 (Kang et al., 2001;  Lee et al., 2001;  
Yu et al., 2000). An explanation for cell-specific differences may be due to variations in 
subcellular compartmentalized redox status (Imhoff and Hansen, 2010). It is suggested that redox 
status changes in specific subcellular compartments, and each compartment may dictate different 
steps in the Nrf2 pathway (Hansen et al., 2004;  Imhoff and Hansen, 2010). Although we 
observed tBHQ-mediated ROS formation in HTR-8/SVneo cells (data not shown), we have not 
tested the hypothesis that tBHQ-mediated Nrf2 activation is ROS-dependent because this was 
not directly relevant to the objectives of this study. Rather, this study utilized tBHQ as a tool to 
induce Nrf2 and thereby inactivate NF-κB as a means to test the role of NF-κB in the BDE-47-
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stimulated inflammatory response. To better understand the mechanism, further investigation 
using antioxidants treatment and measuring redox status in subcellular compartments will be 
needed.   
In addition to tBHQ, we used another Nrf2 inducer, sulforaphane, to investigate the role of 
NF-κB in BDE-47-stimulated cytokine release. Sulforaphane is an isothiocyanate derived from 
cruciferous vegetables (Keum, 2011). Cytoprotective and anti-inflammatory effects of 
sulforaphane have been reported (Heiss et al., 2001;  Juge et al., 2007). Sulforaphane is an 
electrophile that can react with protein thiols to form thionoacyl adducts and is believed to 
modify cysteine residues in Keap 1 protein to a sulfenic acid (−SOH), causing a conformational 
change of Keap1 (Imhoff and Hansen, 2010;  Keum, 2011). It is reported that the induction of 
Nrf2 by sulforaphane is regulated by posttranslational stabilization, attenuating ubiquitinylation 
and proteosomal degradation of Nrf2 and decreasing protein expression level of Keap1 (Keum et 
al., 2006;  Nguyen et al., 2003). In addition, sulforaphane may affect the activity of a variety of 
intracellular kinases to phosphorylate Nrf2 proteins, which dictates the nucleocytoplasmic 
trafficking of Nrf2 or modulates the Nrf2 protein stability (Rada et al., 2011;  Rojo et al., 2008). 
Our results showed that sulforaphane pretreatment induced Nrf2 transactivation and suppressed 
BDE-47-stimulated IL-6 production in HTR-8/SVneo cells (Figure 4.7B). Although 
sulforaphane stimulated induction of Nrf2-regulated genes such HO-1, NQO1 and TXR1(Juge, 
et al., 2007), further investigation will be necessary to confirm sulforaphane-mediated Nrf2 
activation and to elucidate mechanisms for the anti-inflammatory effect by sulforaphane 
observed in this study. Unlike pretreatment with tBHQ, we did not observe ROS formation with 
sulforaphane pretreatment in the HTR-8/SVneo cells, implicating different mechanisms on Nrf2 
activation by each inducer (data not shown).  
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We have to be cautious in interpreting our results because overproduction of IL-6, IL-8, 
and PGE2 alone may not accurately represent the response of trophoblast cells during an 
inflammatory state nor the impact of BDE-47 exposure on trophoblast cellular function in vivo. 
Although changes in inflammatory mediators play an important role in regulating trophoblast 
function, there are complex interactions between these mediators and trophoblast invasion, 
involving a number of autocrine and paracrine factors such as growth factors, growth factor-
binding proteins, proteoglycans, other cytokines/chemokines, integrins, adhesion and proteolytic 
molecules (Anton, et al., 2012;  Chakraborty et al., 2002;  Lala and Chakraborty, 2003). In 
addition, the impact of BDE-47-stimulate inflammatory responses on trophoblast cellular 
function and invasion should be investigated further to confirm potential relevance of our 
findings to placentation and pregnancy.  
Another limitation of the present study is that the results of in vitro experiments using a 
transformed cell line may not accurately reflect responses of primary extravillous trophoblast 
cells. It has been reported that HTR-8/SVneo cells have a similar phenotype compared to their 
primary counterparts (Biondi et al., 2006; Graham et al., 1993; Jovanović et al., 2010). For 
example, HTR-8/SVneo cells retain migratory capability and express specific placental 
trophoblast markers including HLA-G, cytokeratin-7, and α5β1 integrin up to passage number 
105 (Biondi, et al., 2006;  Khan et al., 2011). However, it has been reported that HTR-8/SVneo 
cells may have a different transcriptomic and epigenetic profile compared to primary extravillous 
trophoblast cells (Bilban et al., 2010;  Novakovic et al., 2011). To address this issue, further 
investigation using primary trophoblasts or placental tissues will be needed to validate the 
potential relevance of our results to pregnancy.  
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Finally, using pharmacological Nrf2 inducers may impact multiple cellular mechanisms 
other than Nrf2 signaling pathways. For example, tBHQ or sulforaphane may bind in a non-
specific manner to other proteins and affect other redox-sensitive transcription factors and 
protein kinases (Reuter, et al., 2010). In addition, the present study did not examine direct anti-
inflammatory effects of Nrf2 activation, but rather presented the concomitant activation of Nrf2-
mediated pathways with suppression of IL-6 release when pretreated with Nrf2 inducers. 
However, our conclusion that Nrf2 activation may be involved in BDE-47-stimulated 
inflammatory responses is supported by the use of two Nrf2 inducers, tBHQ and sulforaphane, 
which activate  Nrf2 pathways by different mechanisms yet resulted in a similar 
antiinflammatory effect in response to BDE-47, . Although our findings implicate Nrf2 
activation as a potential therapeutic target against toxicant-induced inflammatory responses in 
human placental cells, further investigation using genetic knockdown and overexpression of Nrf2 
is warranted to understand the role of Nrf2 on BDE-47-stimulated responses more accurately.  
Despite these limitations, our findings suggest potential adverse impacts of PBDE 
exposure during pregnancy. Invasion of EVTs into maternal spiral arteries is a key event during 
placentation (Brosens et al., 1967;  Pijnenborg et al., 1983;  Pijnenborg et al., 1980), and 
impaired EVT invasion has been attributed to pathologies of adverse birth outcomes with the 
evidence of abnormal placentation (Zhou et al., 1997a;  Zhou et al., 1997b).  The present study 
used HTR-8/SVneo, a human first trimester EVT cell line as a model to study the effects of 
BDE-47 treatment. Because  IL-6, IL-8, and PGE2 have been shown to regulate EVT 
proliferation, migration, and invasion during first trimester of pregnancy (Biondi, et al., 2006;  
Horita et al., 2007a;  Jovanovic, et al., 2010;  Jovanovic and Vicovac, 2009;  Nicola et al., 
2005b),  overproduction of these mediators in HTR-8/SVneo cells by BDE-47 suggests that 
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BDE-47 exposure may disrupt trophoblast cellular function, leading to improper trophoblast 
invasion and abnormal placentation, thereby potentially contributing to adverse obstetrical 
outcomes. Ongoing research in our laboratory on the effects of PBDEs on trophoblast cellular 
function will lead us toward a better understanding of the mechanisms and relevant risks 
associated with PBDE exposures during pregnancy.  
In conclusion, the present study provided the first experimental data to support a 
mechanism by which PBDE exposure could contribute to increased risk for adverse birth 
outcomes. Although inappropriate activation of the innate immune response can lead to placental 
dysfunction and certain environmental contaminants can activate innate immune responses 
(Campbell, 2004;  Lin et al., 2010), there is a paucity of reports on PBDE-stimulated 
inflammation in first trimester placenta. By demonstrating that a common toxicological effect, 
oxidative stress, activates inflammatory pathways associated with impaired trophoblast function 
and placental dysfunction, these data provide support for a plausible biological explanation for 
environmental contaminant exposure associations with adverse obstetrical outcomes. . Given that 
multiple antioxidant trials for preventing adverse birth complications have not  been successful 
(Polyzos et al., 2007;  Rumbold et al., 2008), the activation of Nrf2 antioxidant signaling 
pathways using various synthetic/natural Nrf2 inducers may be a novel approach leading to 
augmentation of intracellular antioxidant capacity (Polyzos et al., 2007;  Rumbold et al., 2008). 
Therefore, this research contributes new information for potential interventions to reduce adverse 
obstetrical outcomes originating from abnormal placental function, with possible economic, 
societal and public health benefits. 
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Figure 5.1. Proposed model of BDE-47 effects in human placental trophoblast cells. 
BDE-47 stimulates production of reactive oxygen species (ROS) with the evidence of decreased 
mitochondrial membrane potential. BDE-47-induced ROS activates a redox-sensitive 
transcription factor NF-kB leading to increased expression of COX-2 and stimulated production 
of proinflammatory PGE2, IL-6, and IL-8. Suppression of IL-6 and PGE2 release by antioxidant 
treatments suggests that BDE-47-stimulated ROS play a role in the initiation of proinflammatory 
responses. BDE-47-stimulated ROS also activate the antioxidative transcription factor Nrf2, 
resulting in differential expression of antioxidant and detoxifying enzymes and increased GSH 
production. Pretreatment with the Nrf2 inducers tBHQ and sulforaphane suppressed BDE-47-
induced NF-kB activity and IL-6 release by stimulating Nrf2 activity, expression of antioxidant 
genes, and GSH production, suggesting the protective role of Nrf2 on BDE-47-stimulated 
inflammatory responses in human trophoblasts. The dotted lines represent relationships that are 
inferred, but are not shown in the present study. 
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